The present disclosure generally relates to methods suitable for use in the manufacture of electronic devices. More particularly, examples of the disclosure relate to methods of forming nitrogen-containing carbon films, to methods of forming structures including such films, and to systems for performing the methods and/or forming the structures.
Nitrogen-containing carbon films can be used in a variety of applications during the manufacture of electronic devices. For example, nitrogen-containing carbon films can be used as optical films, as etching hard mask films, as a gap-fill film for trench patterns, and the like. For some applications, etching resistance, chemical mechanical planarization (CMP) resistance and/or thermal stability may desirably be relatively high. The incorporation of nitrogen in the nitrogen-containing carbon films can produce carbon-containing films that exhibit superior properties, such as increased etch resistance, increased CMP resistance, and/or thermal stability, compared to films that do not include the nitrogen containing material.
For some applications, the nitrogen-containing carbon films may desirably be formed using a plasma process. Use of a plasma process can allow for lower temperatures during the film deposition and/or increased deposition rates of the nitrogen-containing carbon films, compared to thermal processes.
Traditional plasma-assisted processes to form nitrogen-containing carbon films include a plasma strike on the carbon film after film formation and addition of N2 and NH3 in the gas phase during the film formation process. Such techniques generally result in C—NH2 bond termination and dangling bonds, as verified with FTIR analysis. Although such techniques can work well for some applications, in other applications, it may be desirable to have or to increase an amount of carbon-terminated carbon-nitrogen bonds, such as C—N—C and C—N═C, in nitrogen-containing carbon films. The inclusion of carbon-terminated carbon-nitrogen bonds can improve desired chemical properties (e.g., etch and CMP resistance) and physical properties (e.g., optical) of nitrogen-containing carbon films.
Accordingly, improved methods for forming nitrogen-containing carbon films, particularly for methods of forming nitrogen-containing carbon films that include carbon-terminated carbon-nitrogen bonds, such as C—N—C and C—N═C, are desired.
Any discussion, including discussion of problems and solutions, set forth in this section, has been included in this disclosure solely for the purpose of providing a context for the present disclosure, and should not be taken as an admission that any or all of the discussion was known at the time the invention was made or otherwise constitutes prior art.
Various embodiments of the present disclosure relate to methods of forming nitrogen-containing carbon films suitable for use in the formation of electronic devices. While the ways in which various embodiments of the present disclosure address drawbacks of prior methods and structures are discussed in more detail below, in general, exemplary embodiments of the disclosure provide improved methods that include improved precursors and techniques for forming nitrogen-containing carbon films.
In accordance with various embodiments of the disclosure, a method of forming a nitrogen-containing carbon film is provided. Exemplary methods can include providing a precursor to a reaction chamber and forming the nitrogen-containing film on a surface of a substrate using the precursor. Suitable precursors include compounds including carbon-terminated carbon-nitrogen bonds, such as one or more compounds (1) represented by (C—N—C)a and/or (C—N═C)a1, wherein a and a1 are integers that are independently selected and that are greater than or equal to 1 and (2) cyclic compounds having a cyclic structure comprising C, H, O, and N. Exemplary cyclic compounds can include a cyclic skeleton, including, for example, between 5 and 7 atoms. The cyclic skeleton can include nitrogen. In some cases, the cyclic skeleton can consist of one or more of C, O, and N, such as C and N or O, C, and N. A cyclic compound can consist of C, H, O, and N. The cyclic compound can include a cyclic skeleton and one or more atoms (e.g., hydrogen and/or oxygen), groups, and/or side chains attached to the cyclic skeleton. At least one of the one or more sidechains can include CwHxNyOz, wherein w, x, y and z are each individually selected and are each a natural number (including zero). Exemplary methods can further include a step of providing a reactant to the reaction chamber. Exemplary reactants include one or more of hydrogen, nitrogen, a compound comprising hydrogen and nitrogen, and a hydrocarbon.
In accordance with yet further exemplary embodiments of the disclosure, a structure is formed, at least in part, by forming a nitrogen-containing carbon film as described herein.
In accordance with yet further exemplary embodiments of the disclosure, a system is provided for performing a method and/or for forming a structure as described herein.
These and other embodiments will become readily apparent to those skilled in the art from the following detailed description of certain embodiments having reference to the attached figures; the invention not being limited to any particular embodiment(s) disclosed.
A more complete understanding of exemplary embodiments of the present disclosure can be derived by referring to the detailed description and claims when considered in connection with the following illustrative figures.
It will be appreciated that elements in the figures are illustrated for simplicity and clarity and have not necessarily been drawn to scale. For example, the dimensions of some of the elements in the figures may be exaggerated relative to other elements to help improve understanding of illustrated embodiments of the present disclosure.
Although certain embodiments and examples are disclosed below, it will be understood by those in the art that the invention extends beyond the specifically disclosed embodiments and/or uses of the invention and obvious modifications and equivalents thereof. Thus, it is intended that the scope of the invention disclosed should not be limited by the particular disclosed embodiments described below.
The present disclosure generally relates to methods of forming a nitrogen-containing carbon film, to methods of forming structures including such films, to film structures formed using the methods, and to systems for performing the methods and/or forming the film structures.
Exemplary methods described herein can be used to form nitrogen-containing carbon films with carbon-terminated carbon-nitrogen bonds or form nitrogen-containing carbon films with an increased number of carbon-terminated carbon-nitrogen bonds, particularly C—N—C or C—NC. Such films can exhibit desired properties, such as optical properties, increased (e.g., dry) etch resistance, and/or increased CMP resistance. As set forth in more detail below, films including C—N—C or C—N═C can be obtained by using one or more precursors that include C—N—C or C—N═C bonds.
In this disclosure, “gas” can refer to material that is a gas at normal temperature and pressure, a vaporized solid and/or a vaporized liquid, and may be constituted by a single gas or a mixture of gases, depending on the context. A gas other than a process gas, i.e., a gas introduced without passing through a gas distribution assembly, such as a showerhead, other gas distribution device, or the like, may be used for, e.g., sealing a reaction space, which includes a seal gas, such as a rare gas. In some cases, such as in the context of deposition of material, the term “precursor” can refer to a compound that participates in the chemical reaction that produces another compound, and particularly to a compound that constitutes a film matrix or a main skeleton of a film, whereas the term “reactant” can refer to a compound, in some cases other than a precursor, that activates a precursor, modifies a precursor, or catalyzes a reaction of a precursor; a reactant may provide an element (such as O, H, N, C) to a film matrix and become a part of the film matrix when, for example, power (e.g., radio frequency (RF) or microwave power) is applied. In some cases, the terms precursor and reactant can be used interchangeably. The term “inert gas” refers to a gas that does not take part in a chemical reaction to an appreciable extent and/or a gas that excites a precursor (e.g., to facilitate polymerization of the precursor) when, for example, power (e.g., RF power) is applied, but unlike a reactant, it may not become a part of a film matrix to an appreciable extent.
As used herein, the term “substrate” can refer to any underlying material or materials that may be used to form, or upon which, a device, a circuit, or a film may be formed. A substrate can include a bulk material, such as silicon (e.g., single-crystal silicon), other Group IV materials, such as germanium, or compound semiconductor materials, such as Group III-V or Group II-VI semiconductors, and can include one or more layers overlying or underlying the bulk material. Further, the substrate can include various features, such as gaps (e.g., recesses or vias), lines or protrusions, such as lines having gaps formed therebetween, and the like formed on or within or on at least a portion of a layer or bulk material of the substrate. By way of examples, one or more features can have a width of about 10 nm to about 100 nm, a depth or height of about 30 nm to about 1,000 nm, and/or an aspect ratio of about 3.0 to 100.0.
In some embodiments, “film” refers to a layer extending in a direction perpendicular to a thickness direction. In some embodiments, “layer” refers to a material having a certain thickness formed on a surface and can be a synonym of a film or a non-film structure. A film or layer may be constituted by a discrete single film or layer having certain characteristics or multiple films or layers, and a boundary between adjacent films or layers may or may not be clear and may or may not be established based on physical, chemical, and/or any other characteristics, formation processes or sequence, and/or functions or purposes of the adjacent films or layers. The layer or film can be continuous—or not. Further, a single film or layer can be formed using multiple deposition cycles.
As used herein, the term “nitrogen-containing carbon layer” or “nitrogen-containing carbon material” can refer to a layer whose chemical formula can be represented as including carbon and nitrogen. Layers comprising nitrogen-containing carbon material can include other elements, such as one or more of oxygen and hydrogen. Nitrogen-containing carbon layers desirably include one or more of C—N—C and C—N═C.
As used herein, the term “structure” can refer to a partially or completely fabricated device structure. By way of examples, a structure can be a substrate or include a substrate with one or more layers and/or features formed thereon.
As used herein, the term “cyclic deposition process” can refer to a vapor deposition process in which deposition cycles, typically a plurality of consecutive deposition cycles, are conducted in a process chamber. Cyclic deposition processes can include cyclic chemical vapor deposition (CVD) and atomic layer deposition processes. A cyclic deposition process can include one or more cycles that include plasma activation of a precursor, a reactant, and/or an inert gas.
In this disclosure, “continuously” can refer to without breaking a vacuum, without interruption as a timeline, without any material intervening step, immediately thereafter, as a next step, or without an intervening discrete physical or chemical structure between two structures other than the two structures in some embodiments and depending on the context.
In this disclosure, any two numbers of a variable can constitute a workable range of the variable, and any ranges indicated may include or exclude the endpoints. Additionally, any values of variables indicated (regardless of whether they are indicated with “about” or not) may refer to precise values or approximate values and include equivalents, and may refer to average, median, representative, majority, etc. in some embodiments. Further, in this disclosure, the terms “including,” “constituted by” and “having” can refer independently to “typically or broadly comprising,” “comprising,” “consisting essentially of,” or “consisting of” in some embodiments. In this disclosure, any defined meanings do not necessarily exclude ordinary and customary meanings in some embodiments.
Methods in accordance with exemplary embodiments of the disclosure include providing a precursor to a reaction chamber and forming the nitrogen-containing film on a surface of a substrate using the precursor. The methods can also include steps of providing a substrate to a reaction chamber and, in accordance with some examples, providing a reactant to the reaction chamber. The step of forming can be thermally activated or plasma activated.
During the step of providing a precursor to a reaction chamber, one or more precursors are flowed into a reaction chamber of a gas-phase reactor. In accordance with examples of the disclosure, the reaction chamber can form part of a cyclical deposition reactor, such as an atomic layer deposition (ALD) (e.g., PEALD) reactor or chemical vapor deposition (CVD) (e.g., PECVD) reactor. Various steps of methods described herein can be performed within a single reaction chamber or can be performed in multiple reaction chambers, such as reaction chambers of a cluster tool.
During the step of providing a substrate within a reaction chamber, before the step of providing the precursor to the reaction chamber, or during the step of providing the precursor to the reaction chamber, the substrate can be brought to a desired temperature and/or the reaction chamber can be brought to a desired pressure, such as a temperature and/or pressure suitable for subsequent steps. By way of examples, a temperature (e.g., of a substrate or a substrate support) within a reaction chamber can be less than or equal to 400° C. or between about 550° C. and about 650° C. In accordance with particular examples of the disclosure, the substrate includes one or more features, such as recesses.
In accordance with examples of the disclosure, the precursor includes one or more compounds in which one or more nitrogen atoms are bonded to a carbon atom, wherein the carbon atom is a terminal atom.
In accordance with examples of the disclosure, a chemical formula of the precursor comprises one or more of (1) (C—N—C)a and/or (C—N═C)a1, wherein a and a1 are integers that are independently selected and that are greater than or equal to 1 and (2) a cyclic compound, such as a cyclic compound having a cyclic structure comprising C, H, O, and N. A can range from, for example, about 3 to about 6. A1 can range from about 3 to about 6.
In accordance with examples of the disclosure, a cyclic skeleton of a cyclic compound can include between 5 and 7 atoms. The cyclic skeleton can include one or more nitrogen atoms. A nitrogen atom in the cyclic skeleton can form a single bond or a double bond with carbon in the cyclic skeleton. In addition to carbon and/or nitrogen, a cyclic skeleton can include one or more oxygen atoms. In some cases, the cyclic skeleton can consist of one or more of C, O, and N—for example, C and N or C, N and O. In accordance with further examples, the cyclic compound, including the cyclic skeleton, can consist of one or more of C, H, O, and N—e.g., C, H, and N or C, H, N, and O.
A cyclic compound can include one or more atoms, molecules, groups, and/or sidechains attached to the cyclic skeleton. The atoms can include, for example, N, C, O, and H. The molecules or groups can include, for example, methyl groups, ethyl groups, other hydrocarbon groups, hydroxy groups, or the like.
The side chains can include molecules or groups that are represented by the chemical formula CwHxNyOz, wherein w, x, y and z are each individually selected and are each a natural number, and wherein a natural number can be zero. X can range from 0 to 9 or 15, Y can range from 0 to 3 or 6, and Z can range from 0 to 3.
By way of particular examples, the precursor can be selected from one or more of the group consisting of 1,3,5-trimethylhexahydro-1,3,5-triazine; 1,3,5-triazine; 2,4,6-trimethyl-s-triazene; and 1-methyl-2-pyrrolidinone.
The precursor can be a gas, a liquid, or a solid at normal temperature and pressure. In the cases of liquid or solid precursors, the precursor can be heated to a temperature sufficient to form a gas phase of the precursor.
As noted above, methods in accordance with the disclosure can include providing a reactant to the reaction chamber. The reactant can be flowed to the reaction chamber during or overlapping in time with the step of providing a precursor to a reaction chamber. In some cases, the reactant can be pulsed to the reaction chamber. In some cases, the method of forming a nitrogen-containing carbon film includes a cyclic deposition process, where the step of providing a precursor to a reaction and providing a reactant to the reaction chamber can be separated by a purge step. The purge step can include providing a vacuum and/or a purge gas to the reaction chamber.
In accordance with embodiments of the disclosure, a reactant comprises a compound comprising one or more of H, N, and C. In some cases, the compound can consist of one or more of H, N, and C. By way of examples, the reactant can include one or more of hydrogen, nitrogen, a compound comprising hydrogen and nitrogen (e.g., ammonia, hydrazine, or the like), and a hydrocarbon (e.g., comprising only C and H).
In accordance with further examples of the disclosure, although a precursor can include nitrogen, an amount of nitrogen in the nitrogen-containing carbon film can be manipulated by changing a (e.g., volumetric) ratio of a flowrate of the precursor to a flowrate of the reactant.
One or more of the reactant and the precursor can be exposed to a plasma to create an activated species. The plasma can be generated using a direct plasma, as discussed in more detail below, and/or using a remote plasma. In some cases, the reactant can be exposed to a plasma to generate reactant activated species. In some cases, both the precursor and the reactant are exposed to the plasma (e.g., at the same time or during an overlap period). The activated species can be formed using a continuous plasma or a pulsed plasma. In some cases, an inert gas can be continuously flowed to the reaction chamber and activated species can be periodically formed by cycling the power used to form the plasma.
The plasma can be formed using, for example, a capacitively couple plasma (CCP), and inductively coupled plasma (ICP), or a surface plasma, such as a microwave plasma.
A power (e.g., applied to electrodes) to form or maintain the plasma can range from about 50 W to about 600 W. A frequency of the power can range from about 10 kHz to about 100 MHz.
Reactor system 400 includes a pair of electrically conductive flat-plate electrodes 4, 2 in parallel and facing each other in the interior 11 (reaction zone) of a reaction chamber 3. A plasma can be excited within reaction chamber 3 by applying, for example, HRF power (e.g., 13.56 MHz, 27 MHz, microwave frequencies, or the like) from power source 25 to one electrode (e.g., electrode 4) and electrically grounding the other electrode (e.g., electrode 2). A temperature regulator can be provided in a lower stage 2 (the lower electrode), and a temperature of a substrate 1 placed thereon can be kept at a desired temperature. Electrode 4 can serve as a gas distribution device, such as a shower plate. Reactant gas, dilution gas, if any, precursor gas, and/or the like can be introduced into reaction chamber 3 using one or more of a gas line 20, a gas line 21, and a gas line 22, respectively, and through the shower plate 4. Although illustrated with three gas lines, reactor system 400 can include any suitable number of gas lines.
In reaction chamber 3, a circular duct 13 with an exhaust line 7 is provided, through which gas in the interior 11 of the reaction chamber 3 can be exhausted. Additionally, a transfer chamber 5, disposed below the reaction chamber 3, is provided with a seal gas line 24 to introduce seal gas into the interior 11 of the reaction chamber 3 via the interior 16 (transfer zone) of the transfer chamber 5, wherein a separation plate 14 for separating the reaction zone and the transfer zone is provided (a gate valve through which a wafer is transferred into or from the transfer chamber 5 is omitted from this figure). The transfer chamber is also provided with an exhaust line 6. In some embodiments, the deposition and treatment steps are performed in the same reaction space, so that two or more (e.g., all) of the steps can be continuously conducted without exposing the substrate to air or other oxygen-containing atmosphere.
In some embodiments, continuous flow of an inert or carrier gas to reaction chamber 3 can be accomplished using a flow-pass system (FPS), wherein a carrier gas line is provided with a detour line having a precursor reservoir (bottle), and the main line and the detour line are switched, wherein when only a carrier gas is intended to be fed to a reaction chamber, the detour line is closed, whereas when both the carrier gas and a precursor gas are intended to be fed to the reaction chamber, the main line is closed and the carrier gas flows through the detour line and flows out from the bottle together with the precursor gas. In this way, the carrier gas can continuously flow into the reaction chamber and can carry the precursor gas in pulses by switching between the main line and the detour line, without substantially fluctuating pressure of the reaction chamber.
A skilled artisan will appreciate that the apparatus includes one or more controller(s) 26 programmed or otherwise configured to cause one or more method steps as described herein to be conducted. The controller(s) are communicated with the various power sources, heating systems, pumps, robotics and gas flow controllers, or valves of the reactor, as will be appreciated by the skilled artisan.
In some embodiments, a dual chamber reactor (two sections or compartments for processing wafers disposed close to each other) can be used, wherein a reactant gas and a noble gas can be supplied through a shared line, whereas a precursor gas is supplied through unshared lines.
The example embodiments of the disclosure described above do not limit the scope of the invention, since these embodiments are merely examples of the embodiments of the invention. Any equivalent embodiments are intended to be within the scope of this invention. Indeed, various modifications of the disclosure, in addition to those shown and described herein, such as alternative useful combinations of the elements described, may become apparent to those skilled in the art from the description. Such modifications and embodiments are also intended to fall within the scope of the appended claims.
This application claims the benefit of and priority to U.S. Provisional Application No. 63/009,318, filed on Apr. 13, 2020 in the United States Patent and Trademark Office, the disclosure of which is incorporated herein in its entirety by reference.
Number | Name | Date | Kind |
---|---|---|---|
3197682 | Klass et al. | Jul 1965 | A |
3634740 | Stevko | Jan 1972 | A |
3916270 | Wachtler et al. | Oct 1975 | A |
3983401 | Livesay | Sep 1976 | A |
4099041 | Berkman et al. | Jul 1978 | A |
4184188 | Briglia | Jan 1980 | A |
4241000 | McCauley et al. | Dec 1980 | A |
4384918 | Abe | May 1983 | A |
4412133 | Eckes et al. | Oct 1983 | A |
4480284 | Tojo et al. | Oct 1984 | A |
4481300 | Hartnett et al. | Nov 1984 | A |
4496828 | Kusmierz et al. | Jan 1985 | A |
4502094 | Lewin et al. | Feb 1985 | A |
4520116 | Gentilman et al. | May 1985 | A |
4520421 | Sakitani et al. | May 1985 | A |
4535628 | Hope | Aug 1985 | A |
4551192 | Di Milia et al. | Nov 1985 | A |
4554611 | Lewin | Nov 1985 | A |
4700089 | Fujii et al. | Oct 1987 | A |
4720362 | Gentilman et al. | Jan 1988 | A |
4804086 | Grohrock | Feb 1989 | A |
4880982 | Hoksaas | Nov 1989 | A |
4886162 | Ambrogio | Dec 1989 | A |
4931135 | Horiuchi et al. | Jun 1990 | A |
4949671 | Davis et al. | Aug 1990 | A |
4963506 | Liaw et al. | Oct 1990 | A |
5117121 | Watanabe et al. | May 1992 | A |
5124272 | Saito et al. | Jun 1992 | A |
5125710 | Gianelo | Jun 1992 | A |
5186120 | Ohnishi et al. | Feb 1993 | A |
5208961 | Lajoie | May 1993 | A |
5219226 | James | Jun 1993 | A |
5231062 | Mathers et al. | Jul 1993 | A |
5242501 | McDiarmid | Sep 1993 | A |
5250092 | Nakano | Oct 1993 | A |
5252133 | Miyazaki et al. | Oct 1993 | A |
5252134 | Stauffer | Oct 1993 | A |
5280894 | Witcraft et al. | Jan 1994 | A |
5295777 | Hodos | Mar 1994 | A |
5298089 | Bowe et al. | Mar 1994 | A |
5308788 | Fitch et al. | May 1994 | A |
5310410 | Begin et al. | May 1994 | A |
5328360 | Yokokawa | Jul 1994 | A |
5362328 | Gardiner et al. | Nov 1994 | A |
5378501 | Foster et al. | Jan 1995 | A |
5456757 | Aruga et al. | Oct 1995 | A |
5478429 | Komino et al. | Dec 1995 | A |
5518780 | Tamor et al. | May 1996 | A |
5540821 | Tepman | Jul 1996 | A |
5565038 | Ashley | Oct 1996 | A |
5584936 | Pickering et al. | Dec 1996 | A |
5584963 | Takahashi | Dec 1996 | A |
5637153 | Niino et al. | Jun 1997 | A |
5645646 | Beinglass et al. | Jul 1997 | A |
5661263 | Salvaggio | Aug 1997 | A |
5683561 | Hollars et al. | Nov 1997 | A |
5690742 | Ogata et al. | Nov 1997 | A |
5732957 | Yu | Mar 1998 | A |
5804505 | Yamada et al. | Sep 1998 | A |
5851293 | Lane et al. | Dec 1998 | A |
5855687 | DuBois et al. | Jan 1999 | A |
5871586 | Crawley et al. | Feb 1999 | A |
5888304 | Umotoy et al. | Mar 1999 | A |
5897710 | Sato et al. | Apr 1999 | A |
5976973 | Ohira et al. | Nov 1999 | A |
6022180 | Motoyama et al. | Feb 2000 | A |
6022802 | Jang | Feb 2000 | A |
6025117 | Nakano et al. | Feb 2000 | A |
6033215 | Ohsawa | Mar 2000 | A |
6090442 | Klaus et al. | Jul 2000 | A |
6093611 | Gardner et al. | Jul 2000 | A |
6099651 | Sajoto et al. | Aug 2000 | A |
6139983 | Ohashi et al. | Oct 2000 | A |
6143129 | Savas et al. | Nov 2000 | A |
6152669 | Morita et al. | Nov 2000 | A |
6159301 | Sato et al. | Dec 2000 | A |
6176929 | Fukunaga et al. | Jan 2001 | B1 |
6177688 | Linthicum et al. | Jan 2001 | B1 |
6189482 | Zhao et al. | Feb 2001 | B1 |
6217662 | Kong et al. | Apr 2001 | B1 |
6224679 | Sasaki et al. | May 2001 | B1 |
6235121 | Honma et al. | May 2001 | B1 |
6239402 | Araki et al. | May 2001 | B1 |
6239715 | Belton | May 2001 | B1 |
6245647 | Akiyama et al. | Jun 2001 | B1 |
6271320 | Keller et al. | Aug 2001 | B1 |
6328864 | Ishizawa et al. | Dec 2001 | B1 |
6335293 | Luo et al. | Jan 2002 | B1 |
6387823 | Sonderman et al. | May 2002 | B1 |
6452017 | Uhlenbrock et al. | Sep 2002 | B1 |
6462310 | Ratliff et al. | Oct 2002 | B1 |
6464825 | Shinozaki | Oct 2002 | B1 |
6474987 | Huang et al. | Nov 2002 | B1 |
6475902 | Hausmann et al. | Nov 2002 | B1 |
6596398 | Russo et al. | Jul 2003 | B1 |
6623799 | Lee et al. | Sep 2003 | B1 |
6658933 | Allegre et al. | Dec 2003 | B2 |
6659111 | Mouri et al. | Dec 2003 | B1 |
6676759 | Takagi | Jan 2004 | B1 |
6692903 | Chen et al. | Feb 2004 | B2 |
6712949 | Gopal | Mar 2004 | B2 |
6716477 | Komiyama et al. | Apr 2004 | B1 |
6720262 | Koh et al. | Apr 2004 | B2 |
6766545 | Hodges | Jul 2004 | B2 |
6776849 | Aggarwal et al. | Aug 2004 | B2 |
6818566 | Leeson et al. | Nov 2004 | B2 |
6821889 | Elers et al. | Nov 2004 | B2 |
6825106 | Gao et al. | Nov 2004 | B1 |
6843858 | Rossman | Jan 2005 | B2 |
6854580 | Braford | Feb 2005 | B2 |
6867086 | Chen et al. | Mar 2005 | B1 |
6867153 | Tokunaga | Mar 2005 | B2 |
6902647 | Hasper | Jun 2005 | B2 |
RE38937 | Nakamura | Jan 2006 | E |
D524600 | Austin et al. | Jul 2006 | S |
D525127 | Cogley et al. | Jul 2006 | S |
7122844 | Nakamura et al. | Oct 2006 | B2 |
7144806 | Fair et al. | Dec 2006 | B1 |
D535673 | Conway et al. | Jan 2007 | S |
7229502 | Wang et al. | Jun 2007 | B2 |
D549815 | Murphy | Aug 2007 | S |
7297641 | Todd et al. | Nov 2007 | B2 |
7311977 | Yokota et al. | Dec 2007 | B2 |
D562357 | Hardy | Feb 2008 | S |
7410915 | Morisada et al. | Aug 2008 | B2 |
7504344 | Matsuki et al. | Mar 2009 | B2 |
7632549 | Goundar | Dec 2009 | B2 |
7638441 | Morisada et al. | Dec 2009 | B2 |
7662689 | Boyanov et al. | Feb 2010 | B2 |
D614258 | Kojima | Apr 2010 | S |
7727880 | Chattopadhyay et al. | Jun 2010 | B1 |
7858898 | Bailey et al. | Dec 2010 | B2 |
D633452 | Namiki et al. | Mar 2011 | S |
8128333 | Aburatani | Mar 2012 | B2 |
8173554 | Lee et al. | May 2012 | B2 |
8253204 | Lee et al. | Aug 2012 | B2 |
8278224 | Mui et al. | Oct 2012 | B1 |
8318584 | Li et al. | Nov 2012 | B2 |
8404044 | Arai | Mar 2013 | B2 |
8435894 | Chandrashekar et al. | May 2013 | B2 |
8443484 | Ozaki et al. | May 2013 | B2 |
8507720 | Shay | Aug 2013 | B2 |
D693782 | Mori et al. | Nov 2013 | S |
8637384 | Ando et al. | Jan 2014 | B2 |
8784676 | Guha et al. | Jul 2014 | B2 |
8895395 | Kerber et al. | Nov 2014 | B1 |
8937800 | Lubomirsky et al. | Jan 2015 | B2 |
8968989 | Ouattara et al. | Mar 2015 | B2 |
8969934 | Cheng et al. | Mar 2015 | B1 |
8993072 | Xiao et al. | Mar 2015 | B2 |
9117657 | Nakano et al. | Aug 2015 | B2 |
9136108 | Matsushita et al. | Sep 2015 | B2 |
9171714 | Mori et al. | Oct 2015 | B2 |
9214340 | Kurita et al. | Dec 2015 | B2 |
9281223 | Hara | Mar 2016 | B2 |
9337031 | Kim et al. | May 2016 | B2 |
D759193 | Gutierrez et al. | Jun 2016 | S |
D761325 | Abed | Jul 2016 | S |
9428833 | Duvall et al. | Aug 2016 | B1 |
9449843 | Korolik et al. | Sep 2016 | B1 |
9449987 | Miyata et al. | Sep 2016 | B1 |
9455138 | Fukazawa et al. | Sep 2016 | B1 |
9460954 | De Jong et al. | Oct 2016 | B2 |
9472410 | Sadjadi et al. | Oct 2016 | B2 |
9523148 | Pore et al. | Dec 2016 | B1 |
9605736 | Foshage et al. | Mar 2017 | B1 |
D784276 | Tiner et al. | Apr 2017 | S |
9618846 | Shamma et al. | Apr 2017 | B2 |
9653267 | Carducci et al. | May 2017 | B2 |
D793526 | Behdjat | Aug 2017 | S |
D794753 | Miller | Aug 2017 | S |
9748104 | Sasaki et al. | Aug 2017 | B2 |
D797067 | Zhang et al. | Sep 2017 | S |
D798248 | Hanson et al. | Sep 2017 | S |
9754818 | Shiu et al. | Sep 2017 | B2 |
D800782 | Bever et al. | Oct 2017 | S |
9803926 | Kikuchi et al. | Oct 2017 | B2 |
D801942 | Riker et al. | Nov 2017 | S |
D802472 | Sasaki et al. | Nov 2017 | S |
D803802 | Sasaki et al. | Nov 2017 | S |
9812372 | Choi et al. | Nov 2017 | B2 |
9824881 | Niskanen et al. | Nov 2017 | B2 |
9837355 | Briggs et al. | Dec 2017 | B2 |
9842835 | Cheng et al. | Dec 2017 | B1 |
9847247 | Huang et al. | Dec 2017 | B2 |
9850573 | Sun | Dec 2017 | B1 |
D807494 | Kim et al. | Jan 2018 | S |
9911595 | Smith et al. | Mar 2018 | B1 |
9929055 | Dube et al. | Mar 2018 | B2 |
9970112 | Koshi et al. | May 2018 | B2 |
10018920 | Chang et al. | Jul 2018 | B2 |
D825505 | Hanson et al. | Aug 2018 | S |
D825614 | Bever et al. | Aug 2018 | S |
10043661 | Kato et al. | Aug 2018 | B2 |
D829306 | Ikedo et al. | Sep 2018 | S |
D834686 | Yamada et al. | Nov 2018 | S |
10179947 | Fukazawa | Jan 2019 | B2 |
10229851 | Briggs et al. | Mar 2019 | B2 |
10229985 | Li et al. | Mar 2019 | B1 |
D846008 | Geldenhuys et al. | Apr 2019 | S |
D849055 | Kneip | May 2019 | S |
10332747 | Watanabe et al. | Jun 2019 | B1 |
10388513 | Blanquart | Aug 2019 | B1 |
10395963 | Cooke | Aug 2019 | B2 |
10424476 | Suzuki et al. | Sep 2019 | B2 |
10424477 | Niskanen et al. | Sep 2019 | B2 |
D864134 | Watarai et al. | Oct 2019 | S |
10435790 | Fukazawa et al. | Oct 2019 | B2 |
10510529 | Suzuki et al. | Dec 2019 | B2 |
10590535 | Huggare | Mar 2020 | B2 |
D881338 | Chen | Apr 2020 | S |
10622236 | Kuo et al. | Apr 2020 | B2 |
10662525 | Jang et al. | May 2020 | B2 |
10704143 | Hisamitsu et al. | Jul 2020 | B1 |
10731249 | Hatanpää et al. | Aug 2020 | B2 |
10734497 | Zhu et al. | Aug 2020 | B2 |
10741386 | Chen et al. | Aug 2020 | B2 |
10770336 | Hill et al. | Sep 2020 | B2 |
D913980 | Lee et al. | Mar 2021 | S |
D914620 | Rokkam et al. | Mar 2021 | S |
10950477 | Lin et al. | Mar 2021 | B2 |
11018003 | Huang et al. | May 2021 | B2 |
D922229 | Jun et al. | Jun 2021 | S |
11053584 | Hsieh et al. | Jul 2021 | B2 |
20010003271 | Otsuki | Jun 2001 | A1 |
20010007244 | Matsuse | Jul 2001 | A1 |
20010019347 | Hauck | Sep 2001 | A1 |
20010024387 | Raaijmakers et al. | Sep 2001 | A1 |
20010027585 | Lee | Oct 2001 | A1 |
20010042514 | Mizuno et al. | Nov 2001 | A1 |
20010052556 | Ting et al. | Dec 2001 | A1 |
20010054381 | Umotoy et al. | Dec 2001 | A1 |
20020015853 | Wataya et al. | Feb 2002 | A1 |
20020022347 | Park et al. | Feb 2002 | A1 |
20020033183 | Sun et al. | Mar 2002 | A1 |
20020036065 | Yamagishi et al. | Mar 2002 | A1 |
20020047705 | Tada et al. | Apr 2002 | A1 |
20020052119 | Cleemput | May 2002 | A1 |
20020061716 | Korovin et al. | May 2002 | A1 |
20020079056 | Kudo et al. | Jun 2002 | A1 |
20020106909 | Kato et al. | Aug 2002 | A1 |
20020108570 | Lindfors | Aug 2002 | A1 |
20020117262 | Pang et al. | Aug 2002 | A1 |
20020127956 | Ashjaee et al. | Sep 2002 | A1 |
20030008602 | Ashjaee et al. | Jan 2003 | A1 |
20030013314 | Ying et al. | Jan 2003 | A1 |
20030029563 | Kaushal et al. | Feb 2003 | A1 |
20030049571 | Hallock et al. | Mar 2003 | A1 |
20030049580 | Goodman | Mar 2003 | A1 |
20030056726 | Holst et al. | Mar 2003 | A1 |
20030075107 | Miyano et al. | Apr 2003 | A1 |
20030111012 | Takeshima | Jun 2003 | A1 |
20030113995 | Xia et al. | Jun 2003 | A1 |
20030132319 | Hytros et al. | Jul 2003 | A1 |
20030143846 | Sekiya et al. | Jul 2003 | A1 |
20030150386 | Shimada | Aug 2003 | A1 |
20030157345 | Beldi et al. | Aug 2003 | A1 |
20030168174 | Foree | Sep 2003 | A1 |
20030181065 | O'Donnell | Sep 2003 | A1 |
20030200926 | Dando et al. | Oct 2003 | A1 |
20030205237 | Sakuma | Nov 2003 | A1 |
20030232497 | Xi et al. | Dec 2003 | A1 |
20040005753 | Kostamo et al. | Jan 2004 | A1 |
20040018694 | Lee et al. | Jan 2004 | A1 |
20040058517 | Nallan et al. | Mar 2004 | A1 |
20040082171 | Shin et al. | Apr 2004 | A1 |
20040083962 | Bang et al. | May 2004 | A1 |
20040099635 | Nishikawa | May 2004 | A1 |
20040104439 | Haukka et al. | Jun 2004 | A1 |
20040112288 | Whitesell | Jun 2004 | A1 |
20040118342 | Cheng et al. | Jun 2004 | A1 |
20040126929 | Tang et al. | Jul 2004 | A1 |
20040154746 | Park | Aug 2004 | A1 |
20040163590 | Tran et al. | Aug 2004 | A1 |
20040224478 | Chudzik et al. | Nov 2004 | A1 |
20040226507 | Carpenter et al. | Nov 2004 | A1 |
20040241341 | Lin | Dec 2004 | A1 |
20040253790 | Ootsuka | Dec 2004 | A1 |
20040261706 | Lindfors et al. | Dec 2004 | A1 |
20050006682 | Bae et al. | Jan 2005 | A1 |
20050016452 | Ryu et al. | Jan 2005 | A1 |
20050023231 | Huang et al. | Feb 2005 | A1 |
20050051854 | Cabral et al. | Mar 2005 | A1 |
20050062773 | Fouet | Mar 2005 | A1 |
20050074576 | Chaiken et al. | Apr 2005 | A1 |
20050081786 | Kubista et al. | Apr 2005 | A1 |
20050085090 | Mui et al. | Apr 2005 | A1 |
20050090123 | Nishimura et al. | Apr 2005 | A1 |
20050092439 | Keeton et al. | May 2005 | A1 |
20050101154 | Huang | May 2005 | A1 |
20050104112 | Haukka et al. | May 2005 | A1 |
20050133166 | Satitpunwaycha et al. | Jun 2005 | A1 |
20050136657 | Yokoi et al. | Jun 2005 | A1 |
20050142361 | Nakanishi et al. | Jun 2005 | A1 |
20050153573 | Okudaira et al. | Jul 2005 | A1 |
20050164469 | Haupt | Jul 2005 | A1 |
20050170306 | Oosterlaken et al. | Aug 2005 | A1 |
20050193952 | Goodman et al. | Sep 2005 | A1 |
20050285208 | Ren et al. | Dec 2005 | A1 |
20060008997 | Jang et al. | Jan 2006 | A1 |
20060019495 | Marcadal et al. | Jan 2006 | A1 |
20060057858 | Chung et al. | Mar 2006 | A1 |
20060097220 | Kim et al. | May 2006 | A1 |
20060097305 | Lee | May 2006 | A1 |
20060110930 | Senzaki | May 2006 | A1 |
20060115589 | Vukovic | Jun 2006 | A1 |
20060118241 | Ohmi et al. | Jun 2006 | A1 |
20060130751 | Volfovski et al. | Jun 2006 | A1 |
20060133955 | Peters | Jun 2006 | A1 |
20060141758 | Naumann et al. | Jun 2006 | A1 |
20060148151 | Murthy et al. | Jul 2006 | A1 |
20060156979 | Thakur et al. | Jul 2006 | A1 |
20060162661 | Jung et al. | Jul 2006 | A1 |
20060176928 | Nakamura et al. | Aug 2006 | A1 |
20060193980 | Hasegawa | Aug 2006 | A1 |
20060211224 | Matsuda | Sep 2006 | A1 |
20060213441 | Kobrin et al. | Sep 2006 | A1 |
20060223337 | Ahn et al. | Oct 2006 | A1 |
20060249175 | Nowak et al. | Nov 2006 | A1 |
20060252244 | Vaartstra et al. | Nov 2006 | A1 |
20070026654 | Huotari et al. | Feb 2007 | A1 |
20070065597 | Kaido et al. | Mar 2007 | A1 |
20070087515 | Yieh et al. | Apr 2007 | A1 |
20070092696 | Tsukatani et al. | Apr 2007 | A1 |
20070111030 | Nakano et al. | May 2007 | A1 |
20070123060 | Rahtu | May 2007 | A1 |
20070128570 | Goto et al. | Jun 2007 | A1 |
20070134821 | Thakur et al. | Jun 2007 | A1 |
20070144442 | Migita | Jun 2007 | A1 |
20070163490 | Habel et al. | Jul 2007 | A1 |
20070166459 | Chang et al. | Jul 2007 | A1 |
20070205788 | Natsuhara et al. | Sep 2007 | A1 |
20070215278 | Furuse et al. | Sep 2007 | A1 |
20070222131 | Fukumoto et al. | Sep 2007 | A1 |
20070248832 | Maeda et al. | Oct 2007 | A1 |
20070264427 | Shinriki et al. | Nov 2007 | A1 |
20070264793 | Oh et al. | Nov 2007 | A1 |
20070281106 | Lubomirsky et al. | Dec 2007 | A1 |
20080032514 | Sano et al. | Feb 2008 | A1 |
20080044932 | Samoilov et al. | Feb 2008 | A1 |
20080069951 | Chacin et al. | Mar 2008 | A1 |
20080092821 | Otsuka et al. | Apr 2008 | A1 |
20080110401 | Fujikawa et al. | May 2008 | A1 |
20080110568 | Son et al. | May 2008 | A1 |
20080135516 | Yokogawa et al. | Jun 2008 | A1 |
20080135936 | Nakajima | Jun 2008 | A1 |
20080142046 | Johnson et al. | Jun 2008 | A1 |
20080157212 | Lavoie et al. | Jul 2008 | A1 |
20080194088 | Srinivasan et al. | Aug 2008 | A1 |
20080194113 | Kim et al. | Aug 2008 | A1 |
20080210162 | Yonebayashi | Sep 2008 | A1 |
20080223725 | Han et al. | Sep 2008 | A1 |
20080229811 | Zhao et al. | Sep 2008 | A1 |
20080230352 | Hirata | Sep 2008 | A1 |
20080237604 | Alshareef et al. | Oct 2008 | A1 |
20080246101 | Li et al. | Oct 2008 | A1 |
20080276864 | Koelmel et al. | Nov 2008 | A1 |
20080293198 | Kojima et al. | Nov 2008 | A1 |
20090031954 | Nishikido et al. | Feb 2009 | A1 |
20090035463 | Dip | Feb 2009 | A1 |
20090035946 | Pierreux et al. | Feb 2009 | A1 |
20090060480 | Herchen | Mar 2009 | A1 |
20090080136 | Nagayama et al. | Mar 2009 | A1 |
20090093100 | Xia et al. | Apr 2009 | A1 |
20090117723 | Kim et al. | May 2009 | A1 |
20090176018 | Zou et al. | Jul 2009 | A1 |
20090236315 | Willwerth et al. | Sep 2009 | A1 |
20090291566 | Ueno et al. | Nov 2009 | A1 |
20090297696 | Pore et al. | Dec 2009 | A1 |
20090297731 | Goundar | Dec 2009 | A1 |
20090314309 | Sankarakrishnan et al. | Dec 2009 | A1 |
20100008656 | Sorabji et al. | Jan 2010 | A1 |
20100012153 | Shigemoto et al. | Jan 2010 | A1 |
20100031884 | Aggarwal et al. | Feb 2010 | A1 |
20100038687 | Klaus et al. | Feb 2010 | A1 |
20100075488 | Collins et al. | Mar 2010 | A1 |
20100116208 | Sangam | May 2010 | A1 |
20100119844 | Sun et al. | May 2010 | A1 |
20100121100 | Shay | May 2010 | A1 |
20100129670 | Sun et al. | May 2010 | A1 |
20100133255 | Bahng et al. | Jun 2010 | A1 |
20100147396 | Yamagishi et al. | Jun 2010 | A1 |
20100163187 | Yokogawa et al. | Jul 2010 | A1 |
20100178423 | Shimizu et al. | Jul 2010 | A1 |
20100195690 | Moench et al. | Aug 2010 | A1 |
20100258809 | Muller | Oct 2010 | A1 |
20100322822 | Fritchie et al. | Dec 2010 | A1 |
20110089419 | Yamazaki et al. | Apr 2011 | A1 |
20110091650 | Noguchi et al. | Apr 2011 | A1 |
20110100489 | Orito et al. | May 2011 | A1 |
20110117728 | Su et al. | May 2011 | A1 |
20110127702 | Gautam et al. | Jun 2011 | A1 |
20110171380 | Higashi et al. | Jul 2011 | A1 |
20110186984 | Saito et al. | Aug 2011 | A1 |
20110195574 | Blasco et al. | Aug 2011 | A1 |
20110212625 | Toyoda et al. | Sep 2011 | A1 |
20110237082 | Nakajima et al. | Sep 2011 | A1 |
20110254138 | Babich | Oct 2011 | A1 |
20110256692 | Tam et al. | Oct 2011 | A1 |
20110286819 | Shibata et al. | Nov 2011 | A1 |
20110297088 | Song et al. | Dec 2011 | A1 |
20110305856 | Bonn | Dec 2011 | A1 |
20110318142 | Gage et al. | Dec 2011 | A1 |
20120003599 | Patalay et al. | Jan 2012 | A1 |
20120027547 | Jager et al. | Feb 2012 | A1 |
20120055401 | Tozawa | Mar 2012 | A1 |
20120077350 | Miya et al. | Mar 2012 | A1 |
20120088369 | Weidman et al. | Apr 2012 | A1 |
20120094010 | Sugiura et al. | Apr 2012 | A1 |
20120108039 | Zojaji et al. | May 2012 | A1 |
20120111271 | Begarney et al. | May 2012 | A1 |
20120177845 | Odedra et al. | Jul 2012 | A1 |
20120187375 | Guo et al. | Jul 2012 | A1 |
20120196242 | Volfovski et al. | Aug 2012 | A1 |
20120219735 | Bakker et al. | Aug 2012 | A1 |
20120222813 | Pal et al. | Sep 2012 | A1 |
20120231611 | Gatineau et al. | Sep 2012 | A1 |
20120263875 | Brenninger et al. | Oct 2012 | A1 |
20120269962 | Blomberg et al. | Oct 2012 | A1 |
20120270384 | Sanchez et al. | Oct 2012 | A1 |
20120270407 | Werner et al. | Oct 2012 | A1 |
20120276306 | Ueda | Nov 2012 | A1 |
20120320491 | Doh et al. | Dec 2012 | A1 |
20120329208 | Pore et al. | Dec 2012 | A1 |
20130011630 | Sullivan et al. | Jan 2013 | A1 |
20130012003 | Haukka et al. | Jan 2013 | A1 |
20130017503 | De Ridder et al. | Jan 2013 | A1 |
20130037532 | Volfovski et al. | Feb 2013 | A1 |
20130059415 | Kato et al. | Mar 2013 | A1 |
20130062839 | Tschinderle et al. | Mar 2013 | A1 |
20130068391 | Mazzocco et al. | Mar 2013 | A1 |
20130075788 | Tomabechi | Mar 2013 | A1 |
20130085618 | Ding | Apr 2013 | A1 |
20130089988 | Wang et al. | Apr 2013 | A1 |
20130109172 | Collins et al. | May 2013 | A1 |
20130109192 | Hawkins et al. | May 2013 | A1 |
20130147050 | Bonner, III et al. | Jun 2013 | A1 |
20130149874 | Hirose et al. | Jun 2013 | A1 |
20130162142 | Nishino et al. | Jun 2013 | A1 |
20130203258 | Chen et al. | Aug 2013 | A1 |
20130206066 | Han et al. | Aug 2013 | A1 |
20130213300 | Sung et al. | Aug 2013 | A1 |
20130216710 | Masuda et al. | Aug 2013 | A1 |
20130220550 | Koo et al. | Aug 2013 | A1 |
20130230987 | Draeger et al. | Sep 2013 | A1 |
20130247937 | Nunomura et al. | Sep 2013 | A1 |
20130270600 | Helander et al. | Oct 2013 | A1 |
20130273330 | Wang et al. | Oct 2013 | A1 |
20140024223 | Kilpi et al. | Jan 2014 | A1 |
20140057187 | Suzuki et al. | Feb 2014 | A1 |
20140080314 | Sasajima et al. | Mar 2014 | A1 |
20140120312 | He et al. | May 2014 | A1 |
20140127422 | Shao et al. | May 2014 | A1 |
20140158154 | Kondo et al. | Jun 2014 | A1 |
20140170320 | Yamamoto et al. | Jun 2014 | A1 |
20140179092 | Kim | Jun 2014 | A1 |
20140187022 | Falster et al. | Jul 2014 | A1 |
20140190581 | Nagase et al. | Jul 2014 | A1 |
20140242808 | Akiyama et al. | Aug 2014 | A1 |
20140252710 | Cuvalci et al. | Sep 2014 | A1 |
20140256160 | Wada et al. | Sep 2014 | A1 |
20140271081 | Lavitsky et al. | Sep 2014 | A1 |
20140290573 | Okabe et al. | Oct 2014 | A1 |
20140327117 | Bencher et al. | Nov 2014 | A1 |
20140346600 | Cheng et al. | Nov 2014 | A1 |
20140360430 | Armour et al. | Dec 2014 | A1 |
20150004806 | Ndiege et al. | Jan 2015 | A1 |
20150024567 | Tsai et al. | Jan 2015 | A1 |
20150030782 | Ivanov et al. | Jan 2015 | A1 |
20150061078 | Abel et al. | Mar 2015 | A1 |
20150069354 | Helander et al. | Mar 2015 | A1 |
20150104575 | Takoudis et al. | Apr 2015 | A1 |
20150110968 | Lavoie et al. | Apr 2015 | A1 |
20150126036 | Zhao | May 2015 | A1 |
20150132953 | Nowling et al. | May 2015 | A1 |
20150137315 | Chen et al. | May 2015 | A1 |
20150155140 | Lee et al. | Jun 2015 | A1 |
20150155370 | Tsai et al. | Jun 2015 | A1 |
20150170907 | Haukka et al. | Jun 2015 | A1 |
20150176124 | Greer et al. | Jun 2015 | A1 |
20150247259 | Hekmatshoar-Tabari et al. | Sep 2015 | A1 |
20150249013 | Arghavani et al. | Sep 2015 | A1 |
20150267299 | Hawkins et al. | Sep 2015 | A1 |
20150275355 | Mallikarjunan et al. | Oct 2015 | A1 |
20150307989 | Lindfors | Oct 2015 | A1 |
20150311043 | Sun et al. | Oct 2015 | A1 |
20150340266 | Ngo et al. | Nov 2015 | A1 |
20160005596 | Behera | Jan 2016 | A1 |
20160010208 | Huang et al. | Jan 2016 | A1 |
20160032453 | Qian et al. | Feb 2016 | A1 |
20160035542 | Hausmann | Feb 2016 | A1 |
20160086811 | Mackedanz et al. | Mar 2016 | A1 |
20160101979 | Hocke | Apr 2016 | A1 |
20160111304 | Takahashi et al. | Apr 2016 | A1 |
20160133504 | Chu et al. | May 2016 | A1 |
20160152649 | Gordon | Jun 2016 | A1 |
20160168704 | Choi et al. | Jun 2016 | A1 |
20160169766 | Ishibashi et al. | Jun 2016 | A1 |
20160204005 | Oki et al. | Jul 2016 | A1 |
20160204436 | Barker et al. | Jul 2016 | A1 |
20160211166 | Yan et al. | Jul 2016 | A1 |
20160215387 | Liu et al. | Jul 2016 | A1 |
20160225588 | Shaikh et al. | Aug 2016 | A1 |
20160237559 | Tsuji | Aug 2016 | A1 |
20160273095 | Lin et al. | Sep 2016 | A1 |
20160273128 | Kang | Sep 2016 | A1 |
20160279629 | Michishita et al. | Sep 2016 | A1 |
20160293609 | Jha et al. | Oct 2016 | A1 |
20160307740 | Kim et al. | Oct 2016 | A1 |
20160314960 | Cheng et al. | Oct 2016 | A1 |
20160343612 | Wang et al. | Nov 2016 | A1 |
20160376701 | Takewaki et al. | Dec 2016 | A1 |
20170022612 | Lei et al. | Jan 2017 | A1 |
20170040146 | Huang et al. | Feb 2017 | A1 |
20170040198 | Lin et al. | Feb 2017 | A1 |
20170062224 | Fu et al. | Mar 2017 | A1 |
20170102612 | Meyers et al. | Apr 2017 | A1 |
20170140924 | Suzuki et al. | May 2017 | A1 |
20170167023 | Proia et al. | Jun 2017 | A1 |
20170178939 | Omori | Jun 2017 | A1 |
20170178942 | Sakata et al. | Jun 2017 | A1 |
20170191685 | Ronne et al. | Jul 2017 | A1 |
20170213960 | de Araujo et al. | Jul 2017 | A1 |
20170218515 | Shin et al. | Aug 2017 | A1 |
20170222008 | Hsu et al. | Aug 2017 | A1 |
20170253968 | Yahata | Sep 2017 | A1 |
20170256393 | Kim et al. | Sep 2017 | A1 |
20170263438 | Li et al. | Sep 2017 | A1 |
20170271143 | Fukiage et al. | Sep 2017 | A1 |
20170283312 | Lee et al. | Oct 2017 | A1 |
20170283313 | Lee et al. | Oct 2017 | A1 |
20170306494 | Lin et al. | Oct 2017 | A1 |
20170314125 | Fenwick et al. | Nov 2017 | A1 |
20170369993 | Sun | Dec 2017 | A1 |
20180047621 | Armini | Feb 2018 | A1 |
20180094350 | Verghese et al. | Apr 2018 | A1 |
20180096821 | Lubomirsky | Apr 2018 | A1 |
20180096844 | Dutartre et al. | Apr 2018 | A1 |
20180105701 | Larsson et al. | Apr 2018 | A1 |
20180119283 | Fukazawa et al. | May 2018 | A1 |
20180171472 | Yamada et al. | Jun 2018 | A1 |
20180209042 | Wu et al. | Jul 2018 | A1 |
20180265294 | Hayashi | Sep 2018 | A1 |
20180265972 | Firouzdor et al. | Sep 2018 | A1 |
20180265973 | Firouzdor et al. | Sep 2018 | A1 |
20180274098 | Takagi et al. | Sep 2018 | A1 |
20180315597 | Varadarajan et al. | Nov 2018 | A1 |
20180327892 | Wu et al. | Nov 2018 | A1 |
20180327898 | Wu et al. | Nov 2018 | A1 |
20180327899 | Wu et al. | Nov 2018 | A1 |
20190019714 | Kosakai et al. | Jan 2019 | A1 |
20190035698 | Tanaka | Jan 2019 | A1 |
20190078206 | Wu et al. | Mar 2019 | A1 |
20190109043 | Wang et al. | Apr 2019 | A1 |
20190115451 | Lee et al. | Apr 2019 | A1 |
20190148177 | Yin et al. | May 2019 | A1 |
20190148556 | Wang et al. | May 2019 | A1 |
20190172701 | Jia et al. | Jun 2019 | A1 |
20190172714 | Bobek et al. | Jun 2019 | A1 |
20190176435 | Bellman et al. | Jun 2019 | A1 |
20190198297 | Aramaki et al. | Jun 2019 | A1 |
20190211450 | Adachi et al. | Jul 2019 | A1 |
20190233446 | MacDonald et al. | Aug 2019 | A1 |
20190318910 | Mori | Oct 2019 | A1 |
20190319100 | Chen et al. | Oct 2019 | A1 |
20190362970 | Wang et al. | Nov 2019 | A1 |
20190362989 | Reuter et al. | Nov 2019 | A1 |
20190363015 | Cheng et al. | Nov 2019 | A1 |
20190378711 | Suzuki et al. | Dec 2019 | A1 |
20190393304 | Guillorn et al. | Dec 2019 | A1 |
20200012081 | Komai | Jan 2020 | A1 |
20200035489 | Huang et al. | Jan 2020 | A1 |
20200052089 | Yu et al. | Feb 2020 | A1 |
20200058469 | Ranjan et al. | Feb 2020 | A1 |
20200066512 | Tois et al. | Feb 2020 | A1 |
20200105895 | Tang et al. | Apr 2020 | A1 |
20200119038 | Hopkins et al. | Apr 2020 | A1 |
20200135915 | Savant et al. | Apr 2020 | A1 |
20200185249 | Rice et al. | Jun 2020 | A1 |
20200185257 | Nishiwaki | Jun 2020 | A1 |
20200203157 | Su | Jun 2020 | A1 |
20200273728 | Benjaminson et al. | Aug 2020 | A1 |
20200283894 | Lehn et al. | Sep 2020 | A1 |
20200312681 | Tanaka et al. | Oct 2020 | A1 |
20200373152 | Blanquart | Nov 2020 | A1 |
20200395199 | Miyama | Dec 2020 | A1 |
20200402846 | Collins et al. | Dec 2020 | A1 |
20210013034 | Wu et al. | Jan 2021 | A1 |
20210032754 | White et al. | Feb 2021 | A1 |
20210033977 | Raaijmakers et al. | Feb 2021 | A1 |
20210054500 | Zope et al. | Feb 2021 | A1 |
20210054504 | Wang et al. | Feb 2021 | A1 |
20210057214 | Kengoyama et al. | Feb 2021 | A1 |
20210057223 | Stevens et al. | Feb 2021 | A1 |
20210057275 | Pierreux et al. | Feb 2021 | A1 |
20210057570 | Lin et al. | Feb 2021 | A1 |
20210066075 | Zhang et al. | Mar 2021 | A1 |
20210066079 | Lima et al. | Mar 2021 | A1 |
20210066080 | Mattinen et al. | Mar 2021 | A1 |
20210066083 | Haukka | Mar 2021 | A1 |
20210066084 | Raisanen et al. | Mar 2021 | A1 |
20210070783 | Odedra et al. | Mar 2021 | A1 |
20210071296 | Watarai et al. | Mar 2021 | A1 |
20210071298 | Maes et al. | Mar 2021 | A1 |
20210074527 | Lee et al. | Mar 2021 | A1 |
20210082692 | Kikuchi | Mar 2021 | A1 |
20210090878 | Kang et al. | Mar 2021 | A1 |
20210095372 | Minjauw et al. | Apr 2021 | A1 |
20210102289 | Tsuji et al. | Apr 2021 | A1 |
20210102290 | Acosta et al. | Apr 2021 | A1 |
20210102292 | Lin et al. | Apr 2021 | A1 |
20210104384 | Parkhe | Apr 2021 | A1 |
20210104399 | Kuroda et al. | Apr 2021 | A1 |
20210108328 | Yanagisawa | Apr 2021 | A1 |
20210111025 | Zyulkov et al. | Apr 2021 | A1 |
20210111053 | De Ridder | Apr 2021 | A1 |
20210118667 | Fukazawa et al. | Apr 2021 | A1 |
20210118679 | Lima et al. | Apr 2021 | A1 |
20210118687 | Wang et al. | Apr 2021 | A1 |
20210125827 | Khazaka et al. | Apr 2021 | A1 |
20210125832 | Bhatnagar | Apr 2021 | A1 |
20210134588 | Kohen et al. | May 2021 | A1 |
20210134959 | Lima et al. | May 2021 | A1 |
20210140043 | Thombare et al. | May 2021 | A1 |
20210143003 | Fukuda et al. | May 2021 | A1 |
20210151315 | Pierreux et al. | May 2021 | A1 |
20210151348 | Utsuno et al. | May 2021 | A1 |
20210151352 | Zope et al. | May 2021 | A1 |
20210156024 | Roh et al. | May 2021 | A1 |
20210156030 | Shugrue | May 2021 | A1 |
20210159077 | Longrie et al. | May 2021 | A1 |
20210166910 | Kim et al. | Jun 2021 | A1 |
20210166924 | Moon et al. | Jun 2021 | A1 |
20210166925 | Moon et al. | Jun 2021 | A1 |
20210166940 | Nozawa | Jun 2021 | A1 |
20210172064 | Moon | Jun 2021 | A1 |
20210175052 | Takahashi et al. | Jun 2021 | A1 |
20210180184 | Verni et al. | Jun 2021 | A1 |
20210180188 | Kim et al. | Jun 2021 | A1 |
20210180189 | Shugrue et al. | Jun 2021 | A1 |
20210184111 | Chiang | Jun 2021 | A1 |
20210193458 | Salmi et al. | Jun 2021 | A1 |
20210205758 | Kimtee et al. | Jul 2021 | A1 |
20210207269 | Huang et al. | Jul 2021 | A1 |
20210207270 | de Ridder et al. | Jul 2021 | A1 |
20210210373 | Singu et al. | Jul 2021 | A1 |
20210214842 | Yoon et al. | Jul 2021 | A1 |
20210225615 | Yoshida | Jul 2021 | A1 |
20210225622 | Shoji | Jul 2021 | A1 |
20210225642 | Utsuno et al. | Jul 2021 | A1 |
20210225643 | Kuroda et al. | Jul 2021 | A1 |
20210230744 | Kimtee et al. | Jul 2021 | A1 |
20210230746 | Shiba | Jul 2021 | A1 |
20210233772 | Zhu et al. | Jul 2021 | A1 |
20210238736 | Butail et al. | Aug 2021 | A1 |
20210238742 | Susa et al. | Aug 2021 | A1 |
20210239614 | Muralidhar et al. | Aug 2021 | A1 |
20210242011 | Shero et al. | Aug 2021 | A1 |
20210246556 | Mori | Aug 2021 | A1 |
20210247693 | Maes et al. | Aug 2021 | A1 |
20210249303 | Blanquart | Aug 2021 | A1 |
20210254216 | Mori et al. | Aug 2021 | A1 |
20210254238 | Khazaka et al. | Aug 2021 | A1 |
20210257213 | Kikuchi et al. | Aug 2021 | A1 |
20210257509 | Nishiwaki | Aug 2021 | A1 |
20210265134 | Singh et al. | Aug 2021 | A1 |
20210265158 | Kaneko | Aug 2021 | A1 |
20210268554 | Mori | Sep 2021 | A1 |
20210269914 | Väyrynen et al. | Sep 2021 | A1 |
20210272821 | Oosterlaken | Sep 2021 | A1 |
20210273109 | Yamazaki et al. | Sep 2021 | A1 |
20210280448 | Ganguli et al. | Sep 2021 | A1 |
20210285102 | Yoon et al. | Sep 2021 | A1 |
20210287878 | Um et al. | Sep 2021 | A1 |
20210287912 | Shiba et al. | Sep 2021 | A1 |
20210287928 | Kim et al. | Sep 2021 | A1 |
20210288476 | Wei | Sep 2021 | A1 |
20210292902 | Kajbafvala et al. | Sep 2021 | A1 |
20210296130 | Longrie et al. | Sep 2021 | A1 |
20210296144 | Lin et al. | Sep 2021 | A1 |
20210310125 | Ma et al. | Oct 2021 | A1 |
20210313150 | Kang et al. | Oct 2021 | A1 |
20210313167 | Pore et al. | Oct 2021 | A1 |
20210313170 | Suzuki | Oct 2021 | A1 |
20210313178 | Nakano | Oct 2021 | A1 |
20210313182 | Zhu et al. | Oct 2021 | A1 |
20210317576 | Väyrynen et al. | Oct 2021 | A1 |
20210319982 | Kim et al. | Oct 2021 | A1 |
20210320003 | Sugiura et al. | Oct 2021 | A1 |
20210320010 | Wang et al. | Oct 2021 | A1 |
20210320020 | Oosterlaken et al. | Oct 2021 | A1 |
20210324510 | Kuwano et al. | Oct 2021 | A1 |
20210324518 | de Ridder | Oct 2021 | A1 |
20210327704 | Kajbafvala et al. | Oct 2021 | A1 |
20210327714 | Lee et al. | Oct 2021 | A1 |
20210327715 | Xie et al. | Oct 2021 | A1 |
20210328036 | Li et al. | Oct 2021 | A1 |
Number | Date | Country |
---|---|---|
101047143 | Oct 2007 | CN |
101308794 | Sep 2010 | CN |
102094183 | Jun 2011 | CN |
102539019 | Sep 2013 | CN |
203721699 | Jul 2014 | CN |
104307264 | Jan 2015 | CN |
104498895 | Apr 2015 | CN |
104517892 | Apr 2015 | CN |
204629865 | Sep 2015 | CN |
205448240 | Aug 2016 | CN |
104342637 | Feb 2017 | CN |
206145834 | May 2017 | CN |
104233226 | Jun 2017 | CN |
106895521 | Jun 2017 | CN |
104630735 | Dec 2017 | CN |
107675144 | Feb 2018 | CN |
106011785 | Oct 2018 | CN |
108910843 | Nov 2018 | CN |
109000352 | Dec 2018 | CN |
109573996 | Apr 2019 | CN |
0634785 | Jan 1995 | EP |
2708624 | Feb 1995 | FR |
400010 | Oct 1933 | GB |
1488948 | Oct 1977 | GB |
2051875 | Jan 1981 | GB |
S5979545 | May 1984 | JP |
S59127847 | Jul 1984 | JP |
S60110133 | Jun 1985 | JP |
H0165766 | Jun 1989 | JP |
H01185176 | Jul 1989 | JP |
H01313954 | Dec 1989 | JP |
H03211753 | Sep 1991 | JP |
2002019009 | Jan 2002 | JP |
2002118066 | Apr 2002 | JP |
2004088077 | Mar 2004 | JP |
2004244298 | Sep 2004 | JP |
2005033221 | Sep 2004 | JP |
2006124831 | May 2006 | JP |
2015021175 | Feb 2015 | JP |
2017220011 | Dec 2017 | JP |
20000000946 | Jan 2000 | KR |
100273261 | Dec 2000 | KR |
20070041701 | Apr 2007 | KR |
10-2007-0117817 | Dec 2007 | KR |
10-2010-0015073 | Feb 2010 | KR |
10-2010-0122701 | Nov 2010 | KR |
10-2011-0058534 | Jun 2011 | KR |
10-2013-0129149 | Nov 2013 | KR |
101758892 | Jul 2017 | KR |
201213596 | Apr 2012 | TW |
201234453 | Aug 2012 | TW |
201531587 | Aug 2015 | TW |
2004007800 | Jan 2004 | WO |
2007088940 | Aug 2007 | WO |
2013177269 | Nov 2013 | WO |
2015127614 | Sep 2015 | WO |
2016019795 | Feb 2016 | WO |
2017125401 | Jul 2017 | WO |
2019142055 | Jul 2019 | WO |
2019214578 | Nov 2019 | WO |
2020118100 | Jun 2020 | WO |
2021072042 | Apr 2021 | WO |
Entry |
---|
Gordon, “Chemist's Companion—A Handbook of Practical Data, Techniques, and References” 1972, p. 1-2 (Year: 1972). |
Mattox, “Handbook of Physical Vapor Deposition (PVD) Processing—5.5.16 Helicon Plasma Source” 2010, p. 157-193 (Year: 2010). |
JP-2002019009-A, machine translation, originally published 2002, p. 1-11 (Year: 2002). |
CN-109573996-A, machine translation, originally published 2019, p. 1-14 (Year: 2019). |
Wang, J., et al., “Deposition of carbon nitride film from single-source s-triazine precursors”, 2003, Carbon, 41, p. 2031-2037 (Year: 2003). |
CNIPA; Office Action dated Mar. 30, 2021 in Application No. 201610131743.1. |
CNIPA; Office Action dated Mar. 1, 2021 in Application No. 201710131319.1. |
CNIPA; Notice of Allowance dated Mar. 30, 2021 in Application No. 201710762817.6. |
CNIPA; Office Action dated Jan. 28, 2021 in Application No. 201711057557.9. |
CNIPA; Office Action dated Jan. 26, 2021 in Application No. 201711057929.8. |
CNIPA; Office Action dated Apr. 19, 2021 in Application No. 201711328250.8. |
CNIPA; Notice of Allowance dated Apr. 7, 2021 in Application No. 201780044761.9. |
CNIPA; Office Action dated Jan. 29, 2021 in Application No. 201780076230.8. |
CNIPA; Office Action dated Jan. 27, 2021 in Application No. 201780076321.1. |
CNIPA; Office Action dated Mar. 24, 2021 in Application No. 201880048547.5. |
CNIPA; Office Action dated Dec. 22, 2020 in Application No. 201910378791.4. |
CNIPA; Notice of Allowance dated Apr. 7, 2021 in Application No. 202030579755.8. |
EPO; Extended European Search Report dated Apr. 6, 2021 in Application No. 21150514.4. |
JPO; Notice of Allowance dated Apr. 6, 2021 in Application No. 2017-139817. |
JPO; Office Action dated Mar. 31, 2021 in Application No. 2018-024655. |
JPO; Notice of Allowance dated Mar. 17, 2021 in Application No. 2020-010953. |
KIPO; Office Action dated Mar. 23, 2021 in Application No. 10-2014-0011765. |
KIPO; Office Action dated Apr. 27, 2021 in Application No. 10-2014-0027217. |
KIPO; Notice of Allowance dated Apr. 15, 2021 in Application No. 10-2014-0103853. |
KIPO; Notice of Allowance dated Mar. 25, 2021 in Application No. 10-2014-0128626. |
KIPO; Office Action dated Apr. 20, 2021 in Application No. 10-2014-0136089. |
KIPO; Office Action dated Mar. 19, 2021 in Application No. 10-2014-0156196. |
KIPO; Office Action dated Mar. 29, 2021 in Application No. 10-2014-0165685. |
KIPO; Office Action dated Apr. 5, 2021 in Application No. 10-2015-0031720. |
KIPO; Office Action dated Apr. 19, 2021 in Application No. 10-2015-0035094. |
KIPO; Office Action dated Mar. 8, 2021 in Application No. 10-2017-0054647. |
KIPO; Office Action dated Mar. 10, 2021 in Application No. 10-2017-0055703. |
KIPO; Notice of Allowance dated May 24, 2021 in Application No. 10-2020-0101096. |
KIPO; Notice of Allowance dated Apr. 1, 2021 in Application No. 30-2020-0030139 (M001). |
KIPO; Notice of Allowance dated Apr. 1, 2021 in Application No. 30-2020-0030139 (M002). |
TIPO; Notice of Allowance dated May 13, 2021 in Application No. 105122394. |
TIPO; Notice of Allowance dated Mar. 5, 2021 in Application No. 105131284. |
TIPO; Office Action dated Feb. 25, 2021 in Application No. 105134275. |
TIPO; Notice of Allowance dated Mar. 4, 2021 in Application No. 106100823. |
TIPO; Notice of Allowance dated May 6, 2021 in Application No. 106108522. |
TIPO; Notice of Allowance dated Mar. 4, 2021 in Application No. 106111693. |
TIPO; Office Action dated Feb. 25, 2021 in Application No. 106121797. |
TIPO; Office Action dated Apr. 26, 2021 in Application No. 106122231. |
TIPO; Office Action dated Apr. 22, 2021 in Application No. 106124126. |
TIPO; Office Action dated Apr. 22, 2021 in Application No. 106124128. |
TIPO; Notice of Allowance dated Mar. 25, 2021 in Application No. 106124130. |
TIPO; Office Action dated Mar. 4, 2021 in Application No. 106127948. |
TIPO; Office Action dated Mar. 15, 2021 in Application No. 106129971. |
TIPO; Office Action dated Apr. 7, 2021 in Application No. 106135925. |
TIPO; Office Action dated Apr. 7, 2021 in Application No. 106136905. |
TIPO; Office Action dated Mar. 29, 2021 in Application No. 106143559. |
TIPO; Office Action dated Mar. 31, 2021 in Application No. 106143570. |
TIPO; Office Action dated Jan. 15, 2021 in Application No. 108142842. |
TIPO; Office Action dated Jan. 25, 2021 in Application No. 108143562. |
TIPO; Notice of Allowance dated May 18, 2021 in Application No. 109300595. |
TIPO; Notice of Allowance dated Mar. 30, 2021 in Application No. 109305460. |
USPTO; Notice of Allowance dated Feb. 10, 2021 in U.S. Appl. No. 14/219,839. |
USPTO; Advisory Action dated Apr. 13, 2021 in U.S. Appl. No. 14/829,565. |
USPTO; Non-Final Office Action dated May 12, 2021 in U.S. Appl. No. 14/829,565. |
USPTO; Final Office Action dated Feb. 24, 2021 in U.S. Appl. No. 15/262,990. |
USPTO; Advisory Action dated Apr. 28, 2021 in U.S. Appl. No. 15/262,990. |
USPTO; Final Office Action dated Mar. 25, 2021 in U.S. Appl. No. 15/286,503. |
USPTO; Advisory Action dated Apr. 30, 2021 in U.S. Appl. No. 15/377,439. |
USPTO; Final Office Action dated Jan. 7, 2021 in U.S. Appl. No. 15/380,909. |
USPTO; Non-Final Office Action dated Feb. 9, 2021 in U.S. Appl. No. 15/402,993. |
USPTO; Final Office Action dated May 21, 2021 in U.S. Appl. No. 15/402,993. |
USPTO; Final Office Action dated Jun. 2, 2021 in U.S. Appl. No. 15/611,707. |
USPTO; Advisory Action dated Mar. 25, 2021 in U.S. Appl. No. 15/636,307. |
USPTO; Non-Final Office Action dated Apr. 21, 2021 in U.S. Appl. No. 15/636,307. |
USPTO; Final Office Action dated Mar. 10, 2021 in U.S. Appl. No. 15/690,017. |
USPTO; Notice of Allowance dated Apr. 16, 2021 in U.S. Appl. No. 15/691,241. |
USPTO; Non-Final Office Action dated Mar. 18, 2021 in U.S. Appl. No. 15/835,328. |
USPTO; Notice of Allowance dated Mar. 19, 2021 in U.S. Appl. No. 15/890,037. |
USPTO; Final Office Action dated Apr. 19, 2021 in U.S. Appl. No. 15/909,705. |
USPTO; Non-Final Office Action dated May 20, 2021 in U.S. Appl. No. 15/917,224. |
USPTO; Non-Final Office Action dated Feb. 18, 2021 in U.S. Appl. No. 15/923,834. |
USPTO; Advisory Action dated Apr. 28, 2021 in U.S. Appl. No. 15/940,729. |
USPTO; Notice of Allowance dated Apr. 7, 2021 in U.S. Appl. No. 15/940,759. |
USPTO; Advisory Action dated Feb. 22, 2021 in U.S. Appl. No. 15/962,980. |
USPTO; Final Office Action dated Apr. 13, 2021 in U.S. Appl. No. 15/967,146. |
USPTO; Advisory Action dated Jun. 2, 2021 in U.S. Appl. No. 15/967,146. |
USPTO; Non-Final Office Action dated Feb. 19, 2021 in U.S. Appl. No. 15/974,948. |
USPTO; Non-Final Office Action dated May 25, 2021 in U.S. Appl. No. 15/985,539. |
USPTO; Non-Final Office Action dated Apr. 5, 2021 in U.S. Appl. No. 15/996,286. |
USPTO; Non-Final Office Action dated Feb. 4, 2021 in U.S. Appl. No. 16/000,109. |
USPTO; Non-Final Office Action dated May 19, 2021 in U.S. Appl. No. 16/000,125. |
USPTO; Notice of Allowance dated Feb. 5, 2021 in U.S. Appl. No. 16/000,156. |
USPTO; Non-Final Office Action dated Mar. 19, 2021 in U.S. Appl. No. 16/004,041. |
USPTO; Final Office Action dated Mar. 23, 2021 in U.S. Appl. No. 16/039,817. |
USPTO; Advisory Action dated May 28, 2021 in U.S. Appl. No. 16/039,817. |
USPTO; Final Office Action dated Mar. 8, 2021 in U.S. Appl. No. 16/042,791. |
USPTO; Advisory Action dated May 14, 2021 in U.S. Appl. No. 16/042,791. |
USPTO; Notice of Allowance dated Mar. 10, 2021 in U.S. Appl. No. 16/055,532. |
USPTO; Final Office Action dated Mar. 23, 2021 in U.S. Appl. No. 16/105,745. |
USPTO; Final Office Action dated Mar. 24, 2021 in U.S. Appl. No. 16/105,761. |
USPTO; Advisory Action dated May 20, 2021 in U.S. Appl. No. 16/105,761. |
USPTO; Final Office Action dated Mar. 18, 2021 in U.S. Appl. No. 16/105,802. |
USPTO; Advisory Action dated May 27, 2021 in U.S. Appl. No. 16/105,802. |
USPTO; Advisory Action dated Feb. 17, 2021 in U.S. Appl. No. 16/108,950. |
USPTO; Non-Final Office Action dated Apr. 13, 2021 in U.S. Appl. No. 16/108,950. |
USPTO; Notice of Allowance dated Mar. 23, 2021 in U.S. Appl. No. 16/116,708. |
USPTO; Advisory Action dated Mar. 10, 2021 in U.S. Appl. No. 16/117,530. |
USPTO; Non-Final Office Action dated Mar. 23, 2021 in U.S. Appl. No. 16/151,074. |
USPTO; Final Office Action dated May 6, 2021 in U.S. Appl. No. 16/152,260. |
USPTO; Notice of Allowance dated Feb. 24, 2021 in U.S. Appl. No. 16/167,164. |
USPTO; Non-Final Office Action dated Feb. 19, 2021 in U.S. Appl. No. 16/172,535. |
USPTO; Final Office Action dated May 27, 2021 in U.S. Appl. No. 16/172,535. |
USPTO; Advisory Action dated Apr. 5, 2021 in U.S. Appl. No. 16/176,517. |
USPTO; Notice of Allowance dated May 13, 2021 in U.S. Appl. No. 16/176,517. |
USPTO; Notice of Allowance dated Feb. 19, 2021 in U.S. Appl. No. 16/183,258. |
USPTO; Notice of Allowance dated Feb. 10, 2021 in U.S. Appl. No. 16/205,899. |
USPTO; Non-Final Office Action dated Mar. 29, 2021 in U.S. Appl. No. 16/206,589. |
USPTO; Advisory Action dated Feb. 25, 2021 in U.S. Appl. No. 16/210,922. |
USPTO; Final Office Action dated Mar. 29, 2021 in U.S. Appl. No. 16/219,555. |
USPTO; Non-Final Office Action dated May 2, 2021 in U.S. Appl. No. 16/240,392. |
USPTO; Advisory Action dated Jan. 26, 2021 in U.S. Appl. No. 16/251,534. |
USPTO; Non-Final Office Action dated Feb. 23, 2021 in U.S. Appl. No. 16/251,534. |
USPTO; Non-Final Office Action dated Mar. 30, 2021 in U.S. Appl. No. 16/252,567. |
USPTO; Non-Final Office Action dated Mar. 4, 2021 in U.S. Appl. No. 16/252,569. |
USPTO; Non-Final Office Action dated Apr. 20, 2021 in U.S. Appl. No. 16/397,045. |
USPTO; Notice of Allowance dated Mar. 10, 2021 in U.S. Appl. No. 16/400,814. |
USPTO; Non-Final Office Action dated May 7, 2021 in U.S. Appl. No. 16/423,824. |
USPTO; Notice of Allowance dated Apr. 28, 2021 in U.S. Appl. No. 16/453,249. |
USPTO; Final Office Action dated May 20, 2021 in U.S. Appl. No. 16/468,258. |
USPTO; Notice of Allowance dated Apr. 26, 2021 in U.S. Appl. No. 16/517,122. |
USPTO; Final Office Action dated May 12, 2021 in U.S. Appl. No. 16/546,543. |
USPTO; Non-Final Office Action dated Feb. 1, 2021 in U.S. Appl. No. 16/563,473. |
USPTO; Non-Final Office Action dated May 10, 2021 in U.S. Appl. No. 16/601,593. |
USPTO; Non-Final Office Action dated Feb. 24, 2021 in U.S. Appl. No. 16/637,134. |
USPTO; Notice of Allowance dated Jun. 2, 2021 in U.S. Appl. No. 16/637,134. |
USPTO; Notice of Allowance dated Apr. 30, 2021 in U.S. Appl. No. 16/685,787. |
USPTO; Non-Final Office Action dated Apr. 5, 2021 in U.S. Appl. No. 16/704,835. |
USPTO; Final Office Action dated Feb. 22, 2021 in U.S. Appl. No. 16/713,311. |
USPTO; Notice of Allowance dated May 20, 2021 in U.S. Appl. No. 16/752,514. |
USPTO; Notice of Allowance dated May 24, 2021 in U.S. Appl. No. 16/765,125. |
USPTO; Non-Final Office Action dated Apr. 15, 2021 in U.S. Appl. No. 16/789,138. |
USPTO; Notice of Allowance dated May 12, 2021 in U.S. Appl. No. 16/800,114. |
USPTO; Non-Final Office Action dated Apr. 5, 2021 in U.S. Appl. No. 16/816,078. |
USPTO; Non-Final Office Action dated May 19, 2021 in U.S. Appl. No. 16/828,753. |
USPTO; Non-Final Office Action dated May 4, 2021 in U.S. Appl. No. 16/872,045. |
USPTO; Non-Final Office Action dated May 3, 2021 in U.S. Appl. No. 16/878,443. |
USPTO; Non-Final Office Action dated Dec. 31, 2020 in U.S. Appl. No. 16/924,595. |
USPTO; Non-Final Office Action dated May 25, 2021 in U.S. Appl. No. 16/935,280. |
USPTO; Non-Final Office Action dated Apr. 14, 2021 in U.S. Appl. No. 17/009,093. |
USPTO; Ex Parte Quayle Action dated Apr. 13, 2021 in U.S. Appl. No. 29/679,620. |
USPTO; Notice of Allowance dated May 19, 2021 in U.S. Appl. No. 29/702,881. |
Aubin et al. “Very low temperature (450° C.) selective epitaxial growth of heavily in situ boron-doped SiGe layers” Semiconductor Science and Technology, 30, 10 pages (2015). |
Barnscheidt et al. “Highly boron-doped germanium layers on Si(001) grown by carbon-mediated epitaxy” Semiconductor Science and Technology, 33, 9 pages (2018). |
Belyansky et al. “Low Temperature Borophosphosilicate Glass (BPSG) Process for High Aspect Ratio Gap Fill” www.electrochem.org/dl/ma/201/pdfs/0705.pdf, downloaded May 15, 2021, 1 page. |
Cheremisin et al. “UV-laser modification and selective ion-beam etching of amorphous vanadium pentoxide thin films” Phys. Status Solidi A, Applications and materials science, 206 (7), pp. 1484-1487 (2009). |
Dingemans et al. “Plasma-Assisted ALD for the Conformal Deposition of SiO2: Process, Material and Electronic Properties” J of the Electrochemical Society, 159(3), H277-H285 (2012). |
G02-1152 “Atomic Layer Deposition of Al2O3 with Alcohol Oxidants for Impeding Substrate Oxidation” Abstract. Oct. 16, 2019 (2019). |
Imamura et al. “Cyclic C4F8 and O2 plasma etching of TiO2 for high-aspect-ratio three-dimensional devices” Template for JJAP Regular Papers, Jan. 2014, p. 29 (2014). |
Kim et al. “A process for topographically selective deposition on 3D nanostructures by ion implantation” ACS Nano, 10, 4, 4451-4458 (2016). |
Lee et al. “Ultraviolet light enhancement of Ta2O5 dry etch rates” J. of Vacuum Science & Technology B: Microelectronics and Nanometer Structures Processing, Measurement, and Phenomena, 18, pp. 293-295 (2000). |
Musschoot et al. “Atomic layer deposition of titanium nitride from TDMAT precursor” Microelectronic Engineering, 86, pp. 72-77 (2009). |
Noircler et al. “Transmission electron microscopy characterization of low temperature boron doped silicon epitaxial films” CrystEngComm, 22(33), pp. 5464-5472 (2020). |
Oyama et al. “Topotactic synthesis of vanadium nitride solid foams” Journal of Materials Research vol. 8. No. 6, pp. 1450-1454 (1993). |
Rimoldi et al. “Atomic Layer Deposition of Rhenium-Aluminum Oxide Thin Films and ReOx Incorporation in a Metal-Organic Framework” Applied Materials & Interfaces, 9, pp. 35067-35074 (2017). |
Standard Motor Products LX249 Ignition Pick Up, Nov. 11, 2005, Amazon.com, May 10, 2021. URL: https://www.amazon.com/Standard-Motor-Products-LX249-Ignition/dp/B000C7ZTS4/ (2005). |
Tao et al. “Improved performance of GeON as charge storage layer in flash memory by optimal annealing” Microelectronics Reliability, vol. 52, pp. 2597-2601 (2012). |
Wirths et al. “Low temperature RPCVD epitaxial growth of Si1xGex using Si2H6 and Ge2H6” Solid-State Electronics, 88, pp. 2-9 (2013). |
Yanguas-Gil et al. “Modulation of the Growth Per Cycle in Atomic Layer Deposition Using Reversible Surface Functionalization” Chemistry of Materials, 25, pp. 4849-4860 (2013). |
CNIPA; Office Action dated Jul. 21, 2021 in Application No. 201610131743.1. |
CNIPA; Office Action dated Jul. 23, 2021 in Application No. 201710131319.1. |
CNIPA; Notice of Allowance dated Jun. 3, 2021 in Application No. 201711057929.8. |
CNIPA; Office Action dated Sep. 13, 2021 in Application No. 201780076230.8. |
CNIPA; Office Action dated Sep. 13, 2021 in Application No. 201780076321.1. |
CNIPA; Office Action dated Apr. 30, 2021 in Application No. 201810018936.5. |
CNIPA; Office Action dated Apr. 16, 2021 in Application No. 201810116717.0. |
CNIPA; Notice of Allowance dated Sep. 15, 2021 in Application No. 201810116717.0. |
CNIPA; Office Action dated May 26, 2021 in Application No. 201810215131.X. |
CNIPA; Office Action dated Jun. 16, 2021 in Application No. 201810344382.8. |
CNIPA; Notice of Allowance dated Oct. 11, 2021 in Application No. 201810344382.8. |
CNIPA; Office Action dated Jul. 5, 2021 in Application No. 201810530514.6. |
CNIPA; Office Action dated Jun. 30, 2021 in Application No. 201810755771.X. |
CNIPA; Office Action dated Sep. 23, 2021 in Application No. 201880048547.5. |
CNIPA; Office Action dated May 19, 2021 in Application No. 201880072606.2. |
CNIPA; Office Action dated May 31, 2021 in Application No. 201910857144.1. |
CNIPA; Office Action dated Jun. 2, 2021 in Application No. 201910920881.1. |
CNIPA; Office Action dated Jul. 5, 2021 in Application No. 201911042495.3. |
CNIPA; Office Action dated Apr. 27, 2021 in Application No. 201911250100.9. |
CNIPA; Office Action dated Jul. 7, 2021 in Application No. 201980011788.7. |
CNIPA; Notice of Allowance dated Jun. 16, 2021 in Application No. 202130111248.6. |
EPO; Extended European Search Report dated Aug. 11, 2021 in Application No. 21169226.4. |
JPO; Notice of Allowance dated Aug. 11, 2021 in Application No. 2018-024655. |
JPO; Office Action dated Aug. 2, 2021 in Application No. 2019-504674. |
JPO; Office Action dated Sep. 10, 2021 in Application No. 2019-531445. |
JPO; Notice of Allowance dated Jun. 30, 2021 in Application No. 2021-004208. |
KIPO; Office Action dated Jun. 28, 2021 in Application No. 10-2014-0027217. |
KIPO; Notice of Allowance dated May 27, 2021 in Application No. 10-2014-0105478. |
KIPO; Notice of Allowance dated Aug. 17, 2021 in Application No. 10-2014-0122903. |
KIPO; Notice of Allowance dated Sep. 8, 2021 in Application No. 10-2014-0136089. |
KIPO; Notice of Allowance dated Jul. 6, 2021 in Application No. 10-2014-0145220. |
KIPO; Notice of Allowance dated Sep. 23, 2021 in Application No. 2014-0156196. |
KIPO; Notice of Allowance dated Jul. 21, 2021 in Application No. 10-2015-0025314. |
KIPO; Office Action dated May 19, 2021 in Application No. 10-2015-0036819. |
KIPO; Office Action dated Jun. 23, 2021 in Application No. 10-2015-0037658. |
KIPO; Office Action dated Sep. 6, 2021 in Application No. 10-2015-0046393. |
KIPO; Office Action dated Jun. 10, 2021 in Application No. 2015-61391. |
KIPO; Office Action dated Sep. 3, 2021 in Application No. 2017-37847. |
KIPO; Office Action dated Aug. 2, 2021 in Application No. 2017-43865. |
KIPO; Office Action dated Oct. 1, 2021 in Application No. 2017-43919. |
KIPO; Office Action dated Sep. 28, 2021 in Application No. 2017-49172. |
KIPO; Notice of Allowance dated Sep. 28, 2021 in Application No. 2017-54647. |
KIPO; Office Action dated in Aug. 30, 2021 in Application No. 2017-81515. |
KIPO; Office Action dated Sep. 10, 2021 in Application No. 2017-86083. |
KIPO; Office Action dated Jun. 29, 2021 in Application No. 10-2017-0066979. |
KIPO; Notice of Allowance dated Jun. 24, 2021 in Application No. 10-2019-0044213. |
KIPO; Office Action dated Jun. 17, 2021 in Application No. 10-2021-0051860. |
KIPO; Office Action dated Aug. 18, 2021 in Application No. 10-2021-0090283. |
KIPO; Notice of Allowance dated Sep. 2, 2021 in Application No. 30-2020-0047043. |
TIPO; Office Action dated Jun. 22, 2021 in Application No. 104108277. |
TIPO; Notice of Allowance dated Sep. 22, 2021 in Application No. 104108277. |
TIPO; Office Action dated Jun. 2, 2021 in Application No. 105129977. |
TIPO; Notice of Allowance dated Sep. 9, 2021 in Application No. 105129977. |
TIPO; Notice of Allowance dated Jun. 4, 2021 in Application No. 105131896. |
TIPO; Notice of Allowance dated Jul. 30, 2021 in Application No. 105134275. |
TIPO; Notice of Allowance dated Feb. 24, 2021 in Application No. 106113604. |
TIPO; Notice of Allowance dated Sep. 3, 2021 in Application No. 106115126. |
TIPO; Office Action dated Jun. 21, 2021 in Application No. 106120902. |
TIPO; Notice of Allowance dated Jun. 30, 2021 in Application No. 106121797. |
TIPO; Notice of Allowance dated Sep. 1, 2021 in Application No. 106122231. |
TIPO; Notice of Allowance dated Jun. 3, 2021 in Application No. 106123203. |
TIPO; Notice of Allowance dated Aug. 24, 2021 in Application No. 106124129. |
TIPO; Notice of Allowance dated Jul. 28, 2021 in Application No. 106129491. |
TIPO; Notice of Allowance dated Aug. 10, 2021 in Application No. 106129971. |
TIPO; Office Action dated Jun. 15, 2021 in Application No. 106133152. |
TIPO; Notice of Allowance dated Oct. 12, 2021 in Application No. 106135925. |
TIPO; Office Action dated Jul. 13, 2021 in Application No. 106138996. |
TIPO; Notice of Allowance dated Sep. 24, 2021 in Application No. 106143559. |
TIPO; Office Action dated Aug. 5, 2021 in Application No. 106143566. |
TIPO; Office Action dated May 26, 2021 in Application No. 106143568. |
TIPO; Notice of Allowance dated Jul. 30, 2021 in Application No. 106143570. |
TIPO; Office Action dated Jun. 7, 2021 in Application No. 107103230. |
TIPO; Office Action dated Aug. 10, 2021 in Application No. 107103230. |
TIPO; Office Action dated Sep. 8, 2021 in Application No. 107105788. |
TIPO; Office Action dated Aug. 3, 2021 in Application No. 107105982. |
TIPO; Office Action dated Aug. 16, 2021 in Application No. 107114888. |
TIPO; Office Action dated Sep. 28, 2021 in Application No. 109112983. |
TIPO; Office Action dated Sep. 13, 2021 in Application No. 109119438. |
TIPO; Office Action dated Oct. 18, 2021 in Application No. 109300594. |
TIPO; Notice of Allowance dated Jun. 9, 2021 in Application No. 109303437. |
TIPO; Notice of Allowance dated Oct. 1, 2021 in Application No. 110118827. |
TIPO; Notice of Allowance dated Jun. 30, 2021 in Application No. 110301018. |
TIPO; Notice of Allowance dated Jul. 29, 2021 in Application No. 110301101. |
TIPO; Notice of Allowance dated Jul. 27, 2021 in Application No. 110302670. |
USPTO; Final Office Action dated Aug. 4, 2021 in U.S. Appl. No. 14/219,879. |
USPTO; Non-Final Office Action dated Jun. 10, 2021 in U.S. Appl. No. 15/262,990. |
USPTO; Final Office Action dated Oct. 1, 2021 in U.S. Appl. No. 15/262,990. |
USPTO; Non-Final Office Action dated Jul. 9, 2021 in U.S. Appl. No. 15/286,503. |
USPTO; Notice of Allowance dated Jun. 29, 2021 in U.S. Appl. No. 15/377,439. |
USPTO; Non-Final Office Action dated Jun. 25, 2021 in U.S. Appl. No. 15/380,909. |
USPTO; Final Office Action dated Jun. 21, 2021 in U.S. Appl. No. 15/380,921. |
USPTO; Advisory Action dated Aug. 30, 2021 in U.S. Appl. No. 15/380,921. |
USPTO; Non-Final Office Action dated Oct. 6, 2021 in U.S. Appl. No. 15/380,921. |
USPTO; Advisory Action dated Jul. 27, 2021 in U.S. Appl. No. 15/402,993. |
USPTO; Final Office Action dated Jun. 9, 2021 in U.S. Appl. No. 15/491,726. |
USPTO; Advisory Action dated Aug. 24, 2021 in U.S. Appl. No. 15/491,726. |
USPTO; Non-Final Office Action dated Sep. 28, 2021 in U.S. Appl. No. 15/491,726. |
USPTO; Notice of Allowance dated Aug. 25, 2021 in U.S. Appl. No. 15/611,707. |
USPTO; Non-Final Office Action dated Sep. 16, 2021 in U.S. Appl. No. 15/636,307. |
USPTO; Advisory Action dated Jun. 11, 2021 in U.S. Appl. No. 15/690,017. |
USPTO; Non-Final Office Action dated Jun. 17, 2021 in U.S. Appl. No. 15/690,017. |
USPTO; Final Office Action dated Jul. 15, 2021 in U.S. Appl. No. 15/726,959. |
USPTO; Advisory Action dated Sep. 21, 2021 in U.S. Appl. No. 15/726,959. |
USPTO; Notice of Allowance dated Sep. 15, 2021 in U.S. Appl. No. 15/835,328. |
USPTO; Advisory Action dated Jun. 11, 2021 in U.S. Appl. No. 15/909,705. |
USPTO; Notice of Allowance dated Jun. 4, 2021 in U.S. Appl. No. 15/923,834. |
USPTO; Final Office Action dated Jun. 28, 2021 in U.S. Appl. No. 15/925,532. |
USPTO; Advisory Action dated Aug. 27, 2021 in U.S. Appl. No. 15/925,532. |
USPTO; Non-Final Office Action dated Oct. 6, 2021 in U.S. Appl. No. 15/925,532. |
USPTO; Non-Final Office Action dated Jun. 16, 2021 in U.S. Appl. No. 15/940,729. |
USPTO; Notice of Allowance dated Sep. 28, 2021 in U.S. Appl. No. 15/940,729. |
USPTO; Non-Final Office Action dated Aug. 2, 2021 in U.S. Appl. No. 15/962,980. |
USPTO; Non-Final Office Action dated Oct. 4, 2021 in U.S. Appl. No. 15/967,146. |
USPTO; Final Office Action dated Aug. 3, 2021 in U.S. Appl. No. 15/974,948. |
USPTO; Advisory Action dated Oct. 21, 2021 in U.S. Appl. No. 15/974,948. |
USPTO; Final Office Action dated Oct. 12, 2021 in U.S. Appl. No. 15/996,286. |
USPTO; Non-Final Office Action dated Jul. 9, 2021 in U.S. Appl. No. 15/997,445. |
USPTO; Final Office Action dated Aug. 5, 2021 in U.S. Appl. No. 16/000,109. |
USPTO; Final Office Action dated Oct. 20, 2021 in U.S. Appl. No. 16/000,125. |
USPTO; Final Office Action dated Sep. 3, 2021 in U.S. Appl. No. 16/004,041. |
USPTO; Non-Final Office Action dated Oct. 22, 2021 in U.S. Appl. No. 16/042,791. |
USPTO; Non-Final Office Action dated Sep. 28, 2021 in U.S. Appl. No. 16/105,745. |
USPTO; Non-Final Office Action dated Sep. 29, 2021 in U.S. Appl. No. 16/105,761. |
USPTO; Non-Final Office Action dated Jun. 25, 2021 in U.S. Appl. No. 16/105,802. |
USPTO; Final Office Action dated Jul. 27, 2021 in U.S. Appl. No. 16/108,950. |
USPTO; Advisory Action dated Oct. 1, 2021 in U.S. Appl. No. 16/108,950. |
USPTO; Non-Final Office Action dated Jun. 18, 2021 in U.S. Appl. No. 16/117,530. |
USPTO; Final Office Action dated Jul. 8, 2021 in U.S. Appl. No. 16/151,074. |
USPTO; Notice of Allowance dated Sep. 17, 2021 in U.S. Appl. No. 16/151,074. |
USPTO; Non-Final Office Action dated Sep. 16, 2021 in U.S. Appl. No. 16/152,260. |
USPTO; Advisory Action dated Aug. 2, 2021 in U.S. Appl. No. 16/172,535. |
USPTO; Non-Final Office Action dated Oct. 15, 2021 in U.S. Appl. No. 16/172,535. |
USPTO; Final Office Action dated Jun. 14, 2021 in U.S. Appl. No. 16/202,941. |
USPTO; Advisory Action dated Aug. 16, 2021 in U.S. Appl. No. 16/202,941. |
USPTO; Non-Final Office Action dated Sep. 20, 2021 in U.S. Appl. No. 16/202,941. |
USPTO; Final Office Action dated Jul. 26, 2021 in U.S. Appl. No. 16/206,589. |
USPTO; Notice of Allowance dated Sep. 13, 2021 in U.S. Appl. No. 16/206,589. |
USPTO; Non-Final Office Action dated Aug. 25, 2021 in U.S. Appl. No. 16/210,922. |
USPTO; Final Office Action dated Sep. 1, 2021 in U.S. Appl. No. 16/240,392. |
USPTO; Notice of Allowance dated Oct. 15, 2021 in U.S. Appl. No. 16/240,392. |
USPTO; Final Office Action dated Sep. 7, 2021 in U.S. Appl. No. 16/251,534. |
USPTO; Final Office Action dated Aug. 18, 2021 in U.S. Appl. No. 16/252,567. |
USPTO; Final Office Action dated Jul. 21, 2021 in U.S. Appl. No. 16/252,569. |
USPTO; Advisory Action dated Jul. 15, 2021 in U.S. Appl. No. 16/468,258. |
USPTO; Non-Final Office Action dated Oct. 21, 2021 in U.S. Appl. No. 16/468,258. |
USPTO; Advisory Action dated Jul. 8, 2021 in U.S. Appl. No. 16/546,543. |
USPTO; Ex Parte Quayle Action dated Aug. 6, 2021 in U.S. Appl. No. 16/563,473. |
USPTO; Notice of Allowance dated Sep. 30, 2021 in U.S. Appl. No. 16/563,473. |
USPTO; Non-Final Office Action dated Oct. 5, 2021 in U.S. Appl. No. 16/588,807. |
USPTO; Notice of Allowance dated Oct. 18, 2021 in U.S. Appl. No. 16/601,593. |
USPTO; Non-Final Office Action dated Jun. 11, 2021 in U.S. Appl. No. 16/671,847. |
USPTO; Non-Final Office Action dated Jun. 24, 2021 in U.S. Appl. No. 16/673,860. |
USPTO; Non-Final Office Action dated Sep. 28, 2021 in U.S. Appl. No. 16/692,859. |
USPTO; Notice of Allowance dated Jul. 20, 2021 in U.S. Appl. No. 16/704,835. |
USPTO; Non-Final Office Action dated Aug. 31, 2021 in U.S. Appl. No. 16/712,707. |
USPTO; Non-Final Office Action dated Sep. 21, 2021 in U.S. Appl. No. 16/736,336. |
USPTO; Final Office Action dated Sep. 15, 2021 in U.S. Appl. No. 16/789,138. |
USPTO; Non-Final Office Action dated Jun. 24, 2021 in U.S. Appl. No. 16/792,058. |
USPTO; Notice of Allowance dated Oct. 19, 2021 in U.S. Appl. No. 16/792,058. |
USPTO; Non-Final Office Action dated Oct. 6, 2021 in U.S. Appl. No. 16/792,544. |
USPTO; Notice of Allowance dated Sep. 27, 2021 in U.S. Appl. No. 16/792,571. |
USPTO; Non-Final Office Action dated Aug. 17, 2021 in U.S. Appl. No. 16/797,346. |
USPTO; Notice of Allowance dated Jul. 21, 2021 in U.S. Appl. No. 16/816,078. |
USPTO; Non-Final Office Action dated Jun. 23, 2021 in U.S. Appl. No. 16/827,012. |
USPTO; Non-Final Office Action dated Feb. 23, 2021 in U.S. Appl. No. 16/827,506. |
USPTO; Notice of Allowance dated May 27, 2021 in U.S. Appl. No. 16/827,506. |
USPTO; Final Office Action dated Oct. 6, 2021 in U.S. Appl. No. 16/828,753. |
USPTO; Non-Final Office Action dated Jul. 28, 2021 in U.S. Appl. No. 16/835,283. |
USPTO; Non-Final Office Action dated Oct. 4, 2021 in U.S. Appl. No. 16/840,960. |
USPTO; Non-Final Office Action dated Aug. 3, 2021 in U.S. Appl. No. 16/849,793. |
USPTO; Non-Final Office Action dated Jun. 15, 2021 in U.S. Appl. No. 16/861,144. |
USPTO; Final Office Action dated Sep. 17, 2021 in U.S. Appl. No. 16/861,144. |
USPTO; Non-Final Office Action dated Sep. 1, 2021 in U.S. Appl. No. 16/867,385. |
USPTO; Final Office Action dated Oct. 7, 2021 in U.S. Appl. No. 16/872,045. |
USPTO; Final Office Action dated Oct. 14, 2021 in U.S. Appl. No. 16/878,443. |
USPTO; Non-Final Office Action dated Oct. 4, 2021 in U.S. Appl. No. 16/886,405. |
USPTO; Non-Final Office Action dated Jul. 28, 2021 in U.S. Appl. No. 16/888,423. |
USPTO; Non-Final Office Action dated Oct. 13, 2021 in U.S. Appl. No. 16/893,206. |
USPTO; Notice of Allowance dated Jun. 17, 2021 in U.S. Appl. No. 16/924,595. |
USPTO; Non-Final Office Action dated Jul. 27, 2021 in U.S. Appl. No. 16/930,193. |
USPTO; Non-Final Office Action dated Jun. 25, 2021 in U.S. Appl. No. 16/930,305. |
USPTO; Non-Final Office Action dated Sep. 14, 2021 in U.S. Appl. No. 16/932,707. |
USPTO; Non-Final Office Action dated Oct. 4, 2021 in U.S. Appl. No. 16/935,275. |
USPTO; Notice of Allowance dated Sep. 22, 2021 in U.S. Appl. No. 16/935,280. |
USPTO; Non-Final Office Action dated Aug. 23, 2021 in U.S. Appl. No. 16/938,868. |
USPTO; Non-Final Office Action dated Oct. 12, 2021 in U.S. Appl. No. 16/944,763. |
USPTO; Non-Final Office Action dated Aug. 19, 2021 in U.S. Appl. No. 16/992,806. |
USPTO; Non-Final Office Action dated Jul. 7, 2021 in U.S. Appl. No. 16/999,065. |
USPTO; Final Office Action dated Oct. 21, 2021 in U.S. Appl. No. 16/999,065. |
USPTO; Final Ofiice Action dated Jul. 23, 2021 in U.S. Appl. No. 17/009,093. |
USPTO; Advisory Action dated Oct. 5, 2021 in U.S. Appl. No. 17/009,093. |
USPTO; Non-Final Office Action dated Sep. 28, 2021 in U.S. Appl. No. 17/023,129. |
USPTO; Notice of Allowance dated Oct. 14, 2021 in U.S. Appl. No. 17/024,092. |
USPTO; Notice of Allowance dated Oct. 4, 2021 in U.S. Appl. No. 17/028,066. |
USPTO; Non-Final Office Action dated Sep. 10, 2021 in U.S. Appl. No. 17/038,514. |
USPTO; Non-Final Office Action dated Oct. 22, 2021 in U.S. Appl. No. 17/073,544. |
USPTO; Non-Final Office Action dated Sep. 30, 2021 in U.S. Appl. No. 17/093,224. |
USPTO; Non-Final Office Action dated Sep. 22, 2021 in U.S. Appl. No. 17/126,275. |
USPTO; Non-Final Office Action dated Sep. 23, 2021 in U.S. Appl. No. 17/254,111. |
USPTO; Non-Final Office Action dated Sep. 27, 2021 in U.S. Appl. No. 17/254,366. |
USPTO; Notice of Allowance dated Jul. 1, 2021 in U.S. Appl. No. 29/679,620. |
USPTO; Notice of Allowance dated Jul. 9, 2021 in U.S. Appl. No. 29/692,490. |
USPTO; Non-Final Office Action dated Jul. 14, 2021 in U.S. Appl. No. 29/695,044. |
USPTO; Notice of Allowance dated Jun. 8, 2021 in U.S. Appl. No. 29/696,472. |
USPTO; Notice of Allowance dated Sep. 21, 2021 in U.S. Appl. No. 29/702,865. |
Alen et al. “Atomic layer deposition of molybdenum nitride thin films for cu metallizations” J of The Electrochemical Society, 152(5) G361-G366 (2005). |
Best et al. “Complex Halides of the Transition Metals. 24.1 Reactions of Dimeric Molybdenum (II) Halide Complexes Containing Strong Metal-Metal Bonds with Bidentate Tertiary Phosphines and Arsines” Inorganic Chemistry, vol. 17, No. 1, pp. 99-104 (1978). |
Blakeney et al. “Atomic Layer Deposition of Aluminum Metal Films Using a Thermally Stable Aluminum Hydride Reducing Agent” Chem. Mater., 30, pp. 1844-1848 (2018). |
Buitrago et al. “SnOx high-efficiency EUV interference lithography gratings towards the ultimate resolution in photolithography” Abstract, 1 page (2016). |
Buitrago et al. “State-of-the-art EUV materials and processes for the 7 nm node and beyond” Proc of SPIE, vol. 10143, 8 pages (2017). |
Cheng et al. “Improved High-Temperature Leakage in High-Density MIM Capcitors by Using a TiLaO Dielectric and an Ir Electrode” IEEE Electron Device Letters, vol. 28, No. 12, 3 pages (2007). |
Firestop Support Plate, Type B, 6 In Apr. 4, 2012, Amazon. Com, May 10, 2021, https://www.amazon.com/AmeriVent-Firestop-Support-Plate-Type/dp/B007R7W951/ (2012). |
Gertsch et al. “SF4 as the Fluorination Reactant for Al2O3 and VO2 Thermal Atomic Layer Etching” Chem. Mater., 31, pp. 3624-3635 (2019). |
Han et al. “Synthesis and characterization of novel zinc precursors for ZnO thin film deposition by atomic layer deposition” Dalton Transactions 49.14 (2020): 4306-4314. |
Hayashi et al. “2,2-Difluoro-1,3-dimethylimidazolidine (DFI). A new fluorinating agent” Chem. Commun. pp. 1618-1619 (2002). |
Imai et al. “Energetic stability and magnetic moment of tri-, tetra-, and octa-ferromagnetic element nitrides predicted by first-principle calculations” J of Alloys and Compounds, vol. 611, 19 pages (2019). |
Jacoby “Chemical deposition methods to the rescue” Cen. Acs. Org., pp. 29-32 (2018). |
Jiang et al. “Sensitizer for EUV Chemically Amplified Resist: Metal versus Halogen” J of Photopolymer Science and Technology, vol. 32, No. 1, pp. 21-25 (2019). |
Kang et al. “Optical Performance of Extreme Ultraviolet Lithography Mask with an Indium Tin Oxide Absorber” J of Nanoscience and Nanotechnology, vol. 12, pp. 3330-3333 (2012). |
Kim et al. “Atomic layer deposition of transition metals for silicide contact formation: Growth characteristics and silicidation” Microelectronic Engineering, 106, pp. 69-75 (2013). |
Lim et al. “Atomic layer deposition of transition metals” Nature Materials, vol. 2 pp. 749-754 (2003). |
Maina et al. “Atomic layer deposition of transition metal films and nanostructures for electronic and catalytic applications” Critical Reviews in Solid State and Materials Sciences, Abstract, 2 pages (2020). |
Miikkulainen et al. “Crystallinity of inorganic films grown by atomic layer deposition: Overview and general trends” Journal of Applied Physics, 112, 102 pages (2013). |
Niskanen et al. “Radical-enhanced atomic layer deposition of metallic copper thin films” Journal of the Electrochemical Society 152(1) pp. G25-G28 (2004). |
O'Hanlon “A User's Guide to Vacuum Technology” Third Edition, Chapter 19, pp. 359-378 (2003). |
Ovanesyan et al. “Atomic Layer Deposition of SiCxNy Using Si2Cl6 and CH3NH2 Plasma” Chem. Mater. 2017, 29, pp. 6269-6278 (2017). |
Park et al. “Superfilling CVD of copper using a catalytic surfactant” Proceedings of the IEEE 2001 International Interconnect Technology Conference, 3 pages (2001). |
Petrov et al. “1,1,2,2-Tetrafluoroethyl-N,N-dimethylamine: a new selective fluorinating agent” J of Fluorine Chemistry, 109, pp. 25-31 (2001). |
Popov et al. “Atomic Layer Deposition of PbI2 Thin Films” Chem. Mater. 31, pp. 1101-1109 (2019). |
Popovici et al. “High-performance (EOT<0.4nm, Jg˜10-7 A/cm2) ALD-deposited Ru\SrTiO3 stack for next generations DRAM pillar capacitor” 2018 IEEE International Electron Devices Meeting (IEDM), 4 pages (2018). |
Puurunen “Surface Chemistry of Atomic Layer Depostion: A Case Study for the Trimethylaluminum/Water Process” Journal of Applied Physics, 97, 55 pages (2005). |
Rahemi et al. “Variation in electron work function with temperature and its effect on the Young's modulus of metals” Scripta Materialia, 99, pp. 41-44 (2015). |
SciFinder Search Results on hydrazido-based precursor for boron nitride films, search conducted Nov. 5, 2020, 5 pages (2020). |
Shiba et al. “Stable yttrium oxyfluoride used in plasma process chamber” J. Vac. Sci. Technol. A, 35(2), 6 pages (2017). |
Shigemoto et al. “Thermal cleaning of silicon nitride with fluorine and additive mixture” 1 page (2007). |
Takaoka et al. “F-Propene-Dialkylamine Reaction Products as Fluorinating Agents” Bulletin of the Chemical Socity of Japan, vol. 52 (11), pp. 3377-3380 (1979). |
Tsoutsou et al. “Atomic layer deposition of LaxZr1—xO2-d (x=0.25) high-k dielectrics for advanced gate stacks” Applied Physics Letters, 94, 3 pages (2009). |
US PPA U.S. Appl. No. 60/545,181, filed Feb. 13, 2004 in the names of Matthew G. Goodman et al., and entitled “Forced Flow Susceptor with Exit Holes and Veins for Improvided Process” pp. 1-15 (2004). |
US PPA U.S. Appl. No. 60/591,258, filed Jul. 26, 2004 in the names of Jeroen Stoutyesdijk et al., and entitled “Susceptor Support for Eliminating Backside Nodules” pp. 1-71 (2004). |
US PPA U.S. Appl. No. 62/504,470, filed May 10, 2017 in the names of Jennifer Y. Sun et al., and entitled “Metal-Oxy-Fluoride Films for Chamber Components” pp. 1-82 (2017). |
Van Asselt et al. “New Palladium Complexes of Cis-Fixed Bidentate Nitrogen Ligands as Catalysts for Carbon-Carbon Bond Formation” Organometallics, 11, pp. 1999-2001 (1992). |
Van Asselt et al. “On the Mechanism of Formation of Homocoupled Products in the Carbon-Carbon Cross-Coupling Reaction Catalyzed by Palladium Complexes Containing Rigid Bidentate Nitrogen Ligands” Organometallics, 13, pp. 1972-1980 (1994). |
Vayrynen et al. “Atomic Layer Deposition of Nickel Nitride Thin Films Using NiCL2 (TMPDA) and Tert-Butylhydrazine as Precursors” Phy. Status Solidi A, 216, 9 pages (2019). |
Vesters et al. “Sensitizers in EUV Chemically Amplified Resist: Mechanism of sensitivity improvement” Proc. SPIE 10583 Extreme Ultraviolet (EUV) Lithography IX, 1058307, 11 pages (2018). |
Wilklow-Marnell et al. “First-row transitional-metal oxalate resists for EUV” J. Micro/Nanolith. MEMS MOEMS 17(4) Oct.-Dec. 2018, 9 pages (2018). |
Zhang et al. “Mechanical Stability of Air-gap Interconnects” Proc. Future Fab International, pp. 81-87 (2008). |
Zientara et al. Journal of the European Ceramic Society, 27, Abstract, 1 page (2007). |
Hayashi et al. “Spectroscopic properties of nitrogen doped hydrogenated amorphous carbon films grown by radio frequency plasma-enhanced chemical vapor deposition,” Journal of Applied Physics. vol. 89, No. 12, pp. 7924-7931 (2001). |
Jung et al., “Double Patterning of Contact Array with Carbon Polymer,” Proc. of SPIE, 6924, 69240C, 1-10 (2008). |
Miller et al. “Carbon nitrides: synthesis and characterization of a new class of functional materials,” Phys. Chem. Chem. Phys., 19, pp. 15613-15638 (2017). |
Number | Date | Country | |
---|---|---|---|
20210320003 A1 | Oct 2021 | US |
Number | Date | Country | |
---|---|---|---|
63009318 | Apr 2020 | US |